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ABSTRACT

THE USE OF SYNTHETIC OLIGODEOXYRIBONUCLEOTIDES IN
DIRECT ANALYSIS OF SINGLE NUCLETIDE VARIATIONS
AND

INHIBITION OF EUKARYOTIC GENE EXPRESSION

by
Daniel Y. Wu

The present thesis work contributes to two areas of molecular genetics,

namely the development of methods for identifying single nucleotides and the
understanding of the mechanism by which antisense oligonucleotides inhibit
eukaryotic gene expression. Three single nucleotide detection methods are
presented. The first method utilizes hybridization with synthetic oligonucleotide
probes to detect single or multiple nucleotide differences between alleles in

genomic DNA without electrophoretic separation. Total genomic DNA (either
digested or undigested with restriction endonucleases) was immobilized in
depressions in an agarose gel (in silu dots) and hybridized with radiolabeled,

allele-specific oligonucleotide probes. We show that this method can be used
to discriminate the DNA of a HLA-B27-positive individual from the DNA of a

HLA-B27-negative individual using a single HLA-B27 sequence-specific
oligonucleotide probe. Insilu dot analysis was also used to detect the

presence of the sickle cell allele in DNA samples from normal donors (jJ^/pA),
homozygous (P^/p^) and heterozygous (P^/p^) sickle cell donors using a pair
of allele-specific oligonucleotide probes for the human p-globin gene.

Two other methods are also capable of discriminating single nucleotide

variations. They are based upon the action of DNA modifying enzymes(DNA
ligases and DNA polymerases) on allele-specific oligonucleotide substrates
annealed to the target DNA sequences. Bacteriophage T4 DNA ligase

effectively joins two adjacent, short synthetic oligonucleotides when guided by
a complementary DNA template. When a single base-pair mismatch exists at
either side of the ligation junction, the efficiency of the enzyme to ligate the two
oligonucleotides decreases. The highly specific nature of this ligation reaction
provides the enzymatic basis for detection of single base-pair variations in a
ligation amplification reaction (LAR). The product of successful ligation, guided
by a completely complementary DNA template, is then amplified either linearly
or exponentially using sequential rounds of template-dependent ligation.
Similarly, the allele-specific polymerase chain reaction (ASPCR)takes
advantage of the decreased rate of primer extension by DNA polymerase from
Thermophilus aquaticus when a single mismatch exist at the 3' end of a
oligonucleotide primer after it is annealed to a DNA template. Two allelespecific primers differing by a single nucleotide and a third primer, downstream

on the opposite strand can be devised such that each allele-specific primer set
(consisting of an allele-specific primer and the down stream primer) will direct

the amplification of a polymerase chain reaction fragment only in the presence
of the allele-specific genomic DNA template. The present work demonstrates
that both LAR and ASPCR can be used to distinguish between the sickle cell

(pS) and the normal p-globin allele (pA).
The second portion of the present thesis addresses the mechanism of

antisense oligonucleotide inhibition of eukaryotic gene expression. We
designed an eukaryotic expression system by introducing a human growth

hormone (hGH)gene into a mouse L-cell line. We tested the ability of
antisense oligodeoxyribonucleotides and oligomethylphosphonates, which are
complementary to the splice junction, translation start site, and a stretch of
poiypurine-polypyrimidine sequences suitable for triple helix formation, to
inhibit the expression of the hGH gene. We show that the antisense

oligonucleotide may operate by a mechanism other than the simple blocking of
complementary DMA sequence in the gene of interest. Furthermore, we also
demonstrate various confounding effects of oligonucleotide cytotoxicity on the
overall antisense inhibition of hGH gene expression.
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CHAPTER I

IINGLE NUCLEOTIDE DiSCRIMlNATION REACTIONS

1.1

INTRODUCTION

1.1.a. Molecular perspective of a gene and Its sequence variants

It is now known that the human genome contains approximately 6 billion

(6 X 109) base-pairs of deoxyribonucleic acid (DMA) per diploid cell [1]. During
the metaphase of the mitotic division, this genetic material condenses to form 22

paired homologous autosomes and a pair of sex-specific chromosomes, XX (in
females) or XY (in males). In all other periods of the cell cycle, DNA in the cell
remains in a relatively uncondensed structure known as chromatin.

The human genome has been estimated to contain 100,000 genes
encoding for a variety of protein and RNA products [2]. If we assume that the

average size of each gene including the introns is 10 kilobases (10 X 103) long,
the entire essential genetic information would be contained in only
approximately 30% of the total genome. The remaining 70% of the human
genome consists of moderately and highly repetitive sequences as well as

noncoding unique sequences between genes. Available DNA sequence data

suggest that about one in every 200 to 500 nucleotides in these noncoding
regions differs from individual to individual [1]. These genetic variations make
up the majority (95%) of the approximately 10^ sequence variabilities within the

human genome [3, 4]. Only an estimated 5% of the genetic variability occurs in

the coding regions which are about ten times less polymorphic than the
noncoding regions. It is not surprising therefore that most of the 10^ sequence

variations thought to exist in the human genome do not exert any effect on the
function or the survival of the individual. Yet, genetic diseases ciearly exist.
With increasingly sensitive methods for detecting DNA sequence variations and
greater knowledge of disease molecular pathology, the etiology of an
increasing number of human diseases will be linked to particular DNA
sequence variants.

Mutations are believed to be responsible for the great majority of the
DNA sequence polymorphisms thus far detected. Most of these sequence
variations result from single nucleotide substitutions, or point mutations. When
occurring in key positions within the coding sequence for a gene product, these

point mutations can affect transcription, translation or message processing
which in turn result in amino acid substitutions, premature protein terminations

(nonsense mutations), aberrant protein formations (frameshift mutations), or
even preventing the formation of the RNA or the protein product entirely.
The thalassemia alleles of the human p-globin gene provide an

illustrative example [5]. Point mutations have been found to occur throughout
the rather small p-globin gene (1.5 kb in size). They affect transcription [6], RNA
cleavage, 3' polyadenylation [7], RNA splicing [8], and translation [9].
Phenotypically, those point mutations that produce either nonfunctional mRNA
or sequence changes at splice junctions generally create the po thalassemia

phenotypic allele, where the p-globin gene expression is completely absent in

the mature erythrocytes of the affected homozygous patient. Other point
mutations, affecting intervening sequences (IVS 1 or 2), coding sequences
(codon 26, 24, 27), or altering the rate of transcription (transcriptional mutants)

all produce p+ thalassemla phenotypic allele, where subnormal levels of p-

globin expression are found. Nevertheless, all patients with homozygous po/po
or p+/p+ thalassemia need to require regular transfusions and have a life
expectancy of 20 to 30 years [1]. In addition to p-thalassemia alleles, single
point mutations also produce molecular defects in the p-globin protein which
affect the function of the hemaglobin tetramer [5]. The most notable pglobinopathies caused by a single point mutation is the sickle cell disease
which is the result of a single A to T transversion mutation in codon 6 of the pglobin gene [10].

The picture that emerges from studies of genetic variability in a single

genetic locus, such as the p-globinopathies, constitutes a redefinition of the
concept of a gene. Since the work of Mendel, a gene was thought to be the

simplest genetic element responsible for the inheritance of a phenotypic trait.
Different alleles of the gene are the alternative forms of the genetic element that
can occupy the same genetic locus and each allele defines the expression of
one specific variant of the phenotypic trait. For example, the color of the eye

would be considered the phenotypic trait specified by a gene responsible for

the eye pigmentation color. Different alleles of that gene expresse themselves
as black, blue, green or other eye colors. Though much of this traditional view
of the gene remains acceptable, it is being restated in light of recent results.

The modern operational definition of a gene includes totality of its alleles
created by the various mutatuins that occurs at that genetic locus, each of which

can alter the gene product (either RNA or protein) or prevent its production. Any
one of these genetic variants may be considered an allele of the gene, though

undoubtedly some alleles will share the same phenotypic expression (i. e. pthalassemia). A gene therefore includes not only sequences encoding the

gene product but other upstream or downstream regulatory sequences that
influence gene expression.

The idea of a gene as a DNA sequence, and alleles of the gene as
variations in that sequence, underscores the importance of devising methods to

detect sequence variations within a genetic locus. Since most variations are
produced by single nucleotide substitutions, the allelic type can be determined
by using single nucleotide determination reactions which identify the
nucleotides present at specific positions, where the variations are known to
occur. This type of allele identification is especially valuable when the gene in
question is represented by many sequence variants, each of which is found at
high frequency in the gene pool. The HLA loci, which encode various

components of the human major histocompatibility complex, provide ideal

candidates for the application of allelic typing. The HLA DQa locus, for an
example, is represented by at least 8 different alleles [11]. Each of the 8 alleles
is a variant of a common consensus sequence. DNA sequencing information
shows that 40 nucleotide positions within a 180-base-long stretch at the DQa
locus are variable. However, by simply identifying the nucleotides located at

positions 24, 49, and 154 of the sequence, the allelic type of a homozygous

individual can be defined. For a heterozygous individual, 5 nucleotide positions
must be defined for an unambiguous identification.
Many of the single base-pair substitutions, in fact, produce disease

alleles. When present in the homozygous state, these mutant alleles produce
mild to severe genetic diseases. The most notable examples of these include

sickle cell anemia, a- and j3-thalassemias, phenylketonuria, hemophilia, aiantitrypsin deficiency, and possibly diseases whose mutations are not known
such as Huntington's Chorea and Cystic Fibrosis [12,13]. As with sickle cell

disease and thalassemla, no corrective measure for most genetic diseases exist
currently. Experimental gene delivery systems for replacement of defective
genes offer some hope for remediation of limited number of genetic diseases
[1]. However, early diagnosis can often facilitate dietary and therapeutic
Interventions that may ameliorate the clinical course of the disease. Therefore,
an Important application of single base-pair discrimination methodologies
would be the precllnlcal or antenatal diagnosis of these genetic diseases.

1.1.b. Single nucleotlde determination reactions

Currently, discrimination of single base-pair sequence variants In human
genomic DMA utilizes one of three types of methodologies: enzymatic
resolution, physical separation, and ollgonucleotlde hybridization (Table 1).
Two aspects of these DNA-based diagnostic approaches generally limit their
usefulness: they are specificity and sensitivity. Specificity Is the ability of the
methodology to Identify the nucleotlde at a given sequence location. Since
different single nucleotlde substitutions give rise to different sequence
combinations and hence different base-pairing stability, the specificity of a
given methodology will then vary with the type of substitution. For obvious
reasons, the specificity will also depend upon the physical-chemical basis of the
nucleotlde determination reaction. On the other hand, sensitivity of a

methodology Is the ability of the methodology to perform the nucleotlde
discrimination using a limited amount of DMA. Given that ten micrograms of

genomic DMA contains only approximately one million (10®) molecules of a

TABLE 1

Single Nucieotide Detection Methodologles
I. Synthetic Oligonucleotide Probe- ASO

a. Hybridization Detection (Wallace et. a!., 1981 & Conner et. a!.,1983)

b. Oligonucleotide competition (Nozari et. al., 1986 & Wu et. al., 1989)
II. Enzymatic Resolution

a. Allele specific enzymatic resolution (Chang and Kan, 1982)
b. Genetic Linkage to RFLP (Wallace et. al., 1983)
c. RNA-DNA heteroduplex recognition (Myers et. al., 1985)

d. Ligation Amplification Reaction- LAR (Wu and Wallace, 1989)
III. Physical Separation

a. Denaturing Gradient Gel (Fischer and Lerman, 1983)
b. Rapid cloning and sequencing (Scharf et. al., 1986)
IV. Sequence Amplification

a. Polymerase Chain Reaction- PCR (Saiki et. al., 1985)
b. Allele Specific PCR (Wu, et. al., 1989)
c. Transcription Amplification System-TAS

homozygous single-copy gene, the sensitivity of a single nucleotide
discrimination methodology is a particularly important factor.

By far the most dramatic improvement in the sensitivity of single
nucleotide discrimination methods has been achieved as a direct result of the

development of the polymerase chain reaction (PGR)[14]. In this method, the
target DNA sequence is amplified by sequential rounds of polymerization using
two oligonucleotide primers complementary to each of the strands on the 5'
ends of a target region. PGR amplifies a given sequence in an exponential

fashion so that a 10^ to 10® fold copies can be synthesized in a limited number
of rounds. Hence, when it is applied to genomic DNA samples prior to testing

for the nucleotide variation PGR improves the sensitivity of the discrimination
methodology by enriching the DNA sequence of interest.
The most general method for selectively detecting particular DNA

sequences is through the use of synthetic oligonucleotide hybridization probes.
Synthetic oligonucleotides possess the property of hybridizing to genomic DNA
in a sequence-specific manner [15, 16, 17]. The stability of the oligonucleotide-

genomic DNA duplex depends on precise base-pairing of the opposing strands
so that any mismatch destabilizes the duplex. In fact, when proper hybridization

and washing conditions are applied, even a single mismatched base-pair will
destabilize the duplex enough to promote the dissociation of the

oligonucleotide probe from the genomic DNA [18]. Gonsequently,

oligonucleotide probes can be designed to hybridize to a given sequence allele
specifically. Two alleles differed by a single base-pair can be differentiated by
the selective hybridization to allele specific oligonucleotide (ASO) probes.

Applications of oligonucleotide competition and stringent washing further
enhance the probe's selectivity [19]. In theory, although ASO can detect all

known variations in a single copy gene, the method often lacks the necessary
sensitivity required for a diagnostic procedure. Subtle differences in the
methods used to prepare the DNA or perform the hybridization could give rise to

false positive and negative results. Recently, PCR amplification and ASO have
been combined to detect several DNA sequence polymorphisms, including
those that cause certain genetic diseases [20, 21, 22]. This combination has

greatly improved the sensitivity of ASO as a single nucleotide DNA detection
methodology.

Enzymatic methods depend upon the ability of proteins to recognize

single base-pair changes in a DNA sequence (Table 1). Type II restriction
endonucleases, which have great specificity for substrate DNA sequence over a
limited region, are the most logical choices for enzyme based single nucleotide
determination methods. Since single base-pair substitutions can either create
or alter a restriction enzyme cleavage site, type II endonuclease digestion
followed by electrophoresis and the use of a labeled DNA probe can identify

nucleotide variations by changes in the hybridization pattern of the probe [23,
24, 25]. For example, the loss of a restriction site would give rise to a longer
DNA-restriction fragment containing the same probe annealing region.

Hybridization of the radioactively labeled probe to DNA from the mutant allele
missing the restriction site would yield a larger labeled DNA-restriction fragment
when compared with the normal DNA. The DNA sequence variations thus

detected are often referred to as restriction fragment length polymorphisms (or
RFLP)[26]. RFLP analysis is generally highly precise owing largely to the
specificity of restriction enzymes. When coupled to PCR, it becomes an
effective detection method for DNA sequence variation [27, 28]. However, since
only approximately one fourth of all possible DNA sequence variations fall

within restriction enzyme recognition sequences, additional methodologies are
needed to detect the other polymorphic sites.

Other enzymes that have been used in enzyme-based single nucleotide
detection methodoiogies include S1 nuclease and RNAse. These methods

depend upon the enzymatic recognition of mismatched bases in DNA-DNA
homoduplexes or RNA-DNA heteroduplexes that are created when RNA and or
DNA from different alleles are allowed to anneal. The mismatched bases create

small unprotected single stranded regions vuinerable to either SI nuclease or
RNAse digestion [29]. These methods are rather tedious and somewhat
unreliable, needing accurate titrations of the enzyme concentration.
The primary physical methods used for detecting single base-pair

variants are denaturing gradient gel electrophoresis [30, 31], rapid cloning and
sequencing [32], and direct sequencing of PGR products [116]. Denaturing
gradient gel electrophoresis takes advantage of the differential electrophoretic
mobility of matched and mismatched duplexes in a gradient of increasing
denaturent concentration. Denaturing gradient gel electrophoresis differs from
the other single nucleotide discrimination methodologies in that it can

distinguish a sample DNA duplex possessing any sequence mismatch from one
that is perfectly complementary; however, it cannot confirm whether the
mismatch is the specific sequence variation that is being searched for. Rapid
cloning and sequencing has become easier since the development of PGR.

Since it provides the actual sequence, it gives the most information about the
sample DNA. Even with PGR amplification, cloning and sequencing continue to
be technically difficult and time consuming.

1.1.c. Design of new single nucieotide detection methodologies

The collective shortcomings of the existing methods suggest a series of

desirable features that would aid in the design of improved techniques for
single nucieotide determination in DNA. These are:

1. A Single nucieotide detection method should be applicable to any
target DNA sequence and should be independent of the nucleotides flanking
the base-pair of interest.

2. An ideal detection method should be capable of identifying
unambiguously, the single nucieotide variation regardless of the nucleotides
involved in the substitution (i.e., transition or transversion mutation).

3. An ideal method should have sufficient sensitivity so that the
technique can be successfully applied to a limited amount of genomic DNA.
4. An ideal method should be technically simple and quick so that it
could be adapted for routine use in the clinical laboratory.

In attempting to design an improved single nucieotide detection method,
we have chosen to base the discrimination upon the highly selective substrate

requirements of certain DNA modifying enzymes. We reasoned that if we could
combine the power of enzymatic selectivity with the known ability of the
synthetic oligonucleotides to participate in specific interactions with DNA, the

discriminating power of the resulting method would be better than if it was
based on either one alone. From the study of Wallace et al. [16], it is clear that
oligonucleotide probes hybridize to longer DNA targets in a manner depending
upon the length and the sequence of the probe. Hybridization of an
oligonucleotide probe is a thermodynamic phenomenon governed by the

equilibrium constant Kann (Kann = kon/koff)- A single nucleotide discrimination
reaction which is based upon oligonucleotide hybridization would attempt to

manipulate all the variables such that Kann of the oligonucleotide interaction
with the positive target DNA template would be greater than Kann of the same
oligonucleotide interaction with a negative target DNA template. For two target
DNA molecules differing by only a single nucleotide, conditions may not always
exist to achieve this result. For example, a normal target DNA sequence with
the nucleotide C at one position may not be distinguished from a mutant

sequence with a T at the same location. This sequence variation would create
a single G-T base-paring mismatch of a probe complementary to the normal
allele. Since a G-T base-pair is nearly as stable as a A-T base-pair [16], the
oligonucleotide probe cannot effectively detect this sequence variation.
However, if the oligonucleotide probe is modified in a subsequent enzymatic
step to produce a product, the discrimination will depend not only upon kon and

koff, but also upon kcat of the modification enzyme as well (kcat = the catalytic
constant of the enzyme). Similar to other enzymes, we suspect that some DNA
modifying enzymes possess substrate specificities preferring complementary
base-paired substrates over mismatch base-paired substrates. In single
nucleotide determination methodologies where oligonucleotide and DNA
modifying enzymes are both used, kcat. kon. and koff can all be manipulated to
produce the maximum discrimination.

Three single nucleotide determination methodologies are described in
the present thesis work, two of which use both oligonucleotides and enzyme to
accomplish the discrimination. The first method attempts to simplify the existing
oligonucleotide hybridization technology by eliminating the cumbersome

electrophoresis and membrane transfer steps. The basis of each methodology
will be presented below.

1.1.c.i.

Direct Analysis of single nucleotlde variation In human DNA

and RNA using In situ Dot Hybridization.

Existing oligonucleotide methodologies involve first digesting the DNA
with a restriction enzyme followed by electrophoretic separation of the DNA
fragments according to molecular sizes and subsequent probe hybridization.

Hybridization may be performed directly on the dried agarose gel or on a

membrane filter to which the DNA fragments have been transferred. These
procedure are rather tedious. Although appropriate for individual genetic

analysis, it is inappropriate for screening of a large number of samples. We
reasoned that this methodology could be simplified by omitting restriction
enzyme digestion and electrophoretic separation of DNA. Hence, hybridization

can be performed directly on genomic DNA immobilized in depressions in an
agarose gel (in Sllu dots). This procedure should allow the efficient screening of
a large number of samples and repeated screening with different probes.
We selected DNA sequences from the human major histocompatibility

complex (HLA)[33] and p-globin gene [34, 35] as known examples of genetic

variations. We demonstrate in the present work that (i) oligonucleotide probes
hybridize to in situ dots of genomic DNA or total RNA samples in a sequence-

specific manner and (ii) even a single base-pair difference in the DNA or RNA
samples may be accurately detected using appropriate oligonucleotide probes.

Some significant applications of this direct oligonucleotide probing technique

include genetic disease diagnosis, carrier screening, HLA typing, polymorphism
analysis, and the analysis of transcription of closely related genes.

1.1.0. ii. Ligation Amplification Reaction (LAP)

Bacteriophage T4-induced DNA ligase catalyzes the ATP dependent

phosphodiester bond formation between the 5' phosphoryl and the 3' hydroxyl
groups of adjacent DNA strands. The mechanism involves the formation of an

enzyme-adenylate complex (A), followed by the transfer of the adenylate from
the enzyme to the 5' phosphoryl group of the substrate (B), and finally the

formation of the phosphodiester bond between the adjacent DNA substrates (C)
[36, 37, 38]. In this process, one molecule of ATP is cleaved into AMP and PPi

with the formation of one phosphodiester bond.

E + ATP —> E..AMP + PPi

E..AMP + 5- P-DUAb

—> AMPP-DNA/, + E

AMPP-DNAi, + DNAa-OH 3'—> DNAa-P-DNA/,+AMP

(A)

(B)

(C)

Duplex DNA molecules with either cohesive ends or blunt ends can

serve as ligation substrates, although cohesive end ligation is far more efficient

[39, 40, 41]. Single stranded DNA is not a substrate [42]. In addition, T4 DNA
ligase can repair single strand breaks (nicks) in double stranded DNA
molecules [43].

Various activators and inhibitors are known for T4 DNA ligase. For
example, polyethylene glycol (PEG) stimulates both cohesive and blunt end

ligation [44]. This phenomenon is thought to be related to the macromolecular

crowding effect of the high molecular weight polymers in aqueous solutions
[45]. High concentrations of salt( NaCI or KCI) have been alternatively

reported to either stimulate or suppress ligase activities in various systems [46,
47]. And polyamines, such as spermidine, are inhibitors at concentrations
above 1-2 mM [47, 48]

In the past, most studies have focussed on the properties of T4 DMA
ligase as it catalyzes the joining of blunt and cohesive ends in the form of
synthetic polynucleotide or plasmid substrates. Comparatively little is known
regarding the nick closing activity of this enzyme. In this section we first present
an analysis of a closely related enzymatic activity of T4 DMA ligase, namely the
joining of adjacent, short synthetic oligodeoxyribonucleotides which are

annealed to a complementary DMA templates. We have designed a series of
synthetic oligodeoxyribonucleotide pairs(8 and 14 nucleotides long )which

are complementary to either normal (pA) or sickle cell (pS) alleles of the pglobin gene at the sequence surrounding the sickle cell mutation. We
demonstrate that T4 DMA ligase can effectively join these oligonucleotide pairs
on complementary DMA templates. When a single base-pair mismatch exists at
either side of the ligation junction, the efficiency of the ligation is greatly

reduced. The specificity of this ligation reaction, as measured by suppression of
inappropriate ligation of mismatched substrates, can be greatly enhanced by
elevating the reaction temperature or increasing the salt concentration in the
reaction mixture.

We also describe the accumulation of adenylated oligonucleotide
intermediates which occurs under mismatched conditions and the influence of

salt and spermidine on the adenylate formation. The highly sequence specific
nature of the oligonucleotide ligation reactions suggests a role that ligase may

play in the maintenance of DNA sequence integrity. This specificity further
forms the basis of LAR, which uses two pairs of ligation substrates flanking the
target base of interest in both directions and on either strand. LAR then takes

the ligation product of one substrate pair through a series of amplification steps
so that the final signal is amplified some 10"^ to 10^ times. We demonstrate that

this system is capable of distinguishing the normal (pA) allele from the sickle

cell (pS) allele. This ligase detection system can be used in conjunction with
other DNA sequence amplification methodologies, such as the polymerase
chain reaction [14, 27].

I.l.c.iii.

Allele Specific Polymerase Chain Reaction

The polymerase chain reaction developed by Saiki et al. [14] provided a
method to rapidly amplify small amounts of a particular target DNA. The
amplified DNA can then be readily analyzed for the presence of a DNA
sequence variation (e. g., the sickle cell mutation) by allele specific

oligonucleotide hybridization, oligomer restriction, ligation of oligonucleotide

pairs or ligation amplification, as we have discussed above. The advantage
provided by PGR lies in the fact that PGR increases the speed of single
nucleotide analysis and reduces the amount of DNA required for it, but does not
change the method of analysis. We postulate that the PGR primers could be
designed for a specific allele such that the presence or the absence of an
amplified fragment provides a direct determination of the genotype. We further
predict that if the 3' nucleotide of one of the primers forms a mismatched base-

pair with the template due to the existence of a single nucleotide variation,
amplification would take place with reduced efficiency. Specific primers would

then direct amplification only from their homologous allele. After multiple
rounds of amplification, the formation of an amplified fragment would Indicate

the presence of the allele In the Initial DNA template.

1.2. MATERIALS AND METHODS

i.2.a. Common Methodologies

Chemical Synthesis of Oiigodeoxyribonucieotide. All

oligodeoxyribonucleotides used in the studies described in the present thesis
were synthesized on a solid support using either a Systec Microsyn 1450 or an

Applied Biosystem 3808 automated DMA synthesizers. The coupling step of
the synthesis involves a reaction of p-cyanoethyl phosphoramidite
mononucleotide with the 5' hydroxyl group of a nucleoside attached to a solid
support [71]. The unreacted 5' hydroxyl groups are then blocked with acetic

anhydride. The third reaction removes the 4',4'-dimethoxytrityl group from the
coupling reaction product under acidic conditions to again deprotect the 5'

hydroxyl group for the next coupling reaction. In this manner, the synthesis of
an oligonucleotide is elongated from the 3' terminus to the 5' terminus. The

oligonucleotides are then purified on a denaturing polyacrylamide gel (20 %
polyacrylamide, 7M urea) followed by HPLC chromatography on a reverse
phase column [18, 72].

5' Phosphorylatlon of Synthetic Oligonucleotides. 5'

phosphorylation of synthetic oligonucleotide probes and of ligation system
substrates(0NA2,0NS2 and 0N4) with radioactive [y-32p] aTP (6000 Ci/mmol;

MEN) or with nonradioactive ATP were accomplished using T4 polynucleotide
kinase (5 units) and 10 pmol of the oligonucleotide substrates in the presence

of 50 mM Tris-HCI[pH 7.6], 10 mM MgCl2, 5 mM DTT, and 0.1 mM spermidine

[72]. The kinase reactions were carried out at 37 °C for 1 hr in a total reaction

volume of 10 |j.l. The labeled oligonucleotide products were then separated

from unreacted

ajp by immobilization on DE52 anion exchange resin

(Whatman), followed by washing with 2 ml of 10 mM Tris-HCI [pH.8.0], 1 mM
EDTA and 2 ml of 10 mM Tris[pH 8.0], 0.2 M NaCI, and then elution with 1 M
NaCI [18]. The specific activity of labelled products ranged from 10^ to 10^
cpm/pmol.

Where the studies called for the use of unlabeled 5' phosphorylation, the
oligonucleotides were phosphorylated with 1 mM unlabeled ATP for 3 hr under

the conditions described above. The unlabeled 5' phosphorylated substrates

were heated in a boiling water bath for 10 min and diluted to the specified
concentration before use in a ligation reaction.

Source and Isolation of Human DMA and RNA. All genomic
DMA, with the exception of the p-thalassemia samples, were isolated from the
peripheral blood of appropriate donors. The HLA-B27 donor, for example, was
serologically typed to be HLA-B27 antigen positive (HM: HLA-B7/B27) and the

HLA-B27 negative individual was serologically typed to be HLA-B27 negative

(DW: NLA B13/Bw60). The sickle cell diseased patient was confirmed by
hemaglobin electrophoresis to have sickle cell anemia. We obtained an EBV

transformed p-thalassemia major lymphocyte culture (GM 2267) from NIGMS

Human Genetic Mutant Cell Repository (Camden, N.J.). The cells originated
from a patient with a homozygous 5-p-globin gene deletion. Thalassemia DMA
was isolated from the cultured cells grown in suspension in RPMI medium.
All DMA preparations were performed according to a modified Triton X-

100 procedure followed by Proteinase K and RNAse treatment [73]. In this

procedure, 10 ml of heparinized whole blood from patients was lysed with 90 ml
of 0.32 M sucrose, 10 mM Tris-HCI (pH 7.5), 5 mM MgCIa, and 1% v/v Triton X100 solution. The nuclei of the leukocytes were Isolated by centrlfugatlon In a

Sorvall SA600 rotor for 10 min at 4000 rpm (1000 g). The pelleted nuclei were
subjected to Protelnase K (10 mg) and RNAse (1 mg)treatment In 5 ml of 75

mM NaCI, 24 mM EDTA, and 0.5 % SDS at 37 ®C overnight. The mixture was
then extracted several times with phenol and chloroform followed by ethanol
precipitation In the presence of 0.3 M sodium acetate. DNA concentrations

were estimated from the spectrophotometric absorption at 260 nm wavelength

assuming 25 pg/ml for one absorption unit. The DNA purity was estimated by
the ratio of absorbance at 280 nm (protein absorption maximum) versus the
absorbance at 260 nm (nucleic acid absorption maximum). Additional phenolchloroform extractions were performed If the ratio exceeded 0.6. The average
yield of genomic DNA per ml of blood sample was approximately 25 pg. For

10^ cells In tissue culture, the average yield was approximately 50 pg.
Total RNA was Isolated from blood by lysing the red blood cells and

retlculocytes at low Ionic strength, precipitating the ribonucleoprotein at low pH,
phenol-extracting the precipitate, and ethanol precipitating the RNA as

described by Goossens and Kan [74]. As expected, the yield of RNA was much
higher (>10 times) from Individuals with sickle cell anemia than from normal

Individuals due to the elevated retlculocyte levels associated with sickle cell
anemia [75]. Yields were typically 30 pg total RNA per 20 ml of blood for normal
Individuals.

Restriction Endonuciease Digestion of DNA for Dry-Gei and Iq

Situ Dot Hybridization Anaiysis. Where indicated, genomic DNA (5-10

p.g) was digested with either Pvu II (5 units/p,g) or Bam HI (10-15 units/ng)
overnight at 37 °C. Restriction digestions with Pvu II were carried out in 50 mM

Tris-HCI (pH 7.5), 60 mM NaCI, 6 mM MgCl2, 100 mg/ml BSA, and 4 mM
spermidine. Bam HI digestions were performed in reaction mixture containing
20 mM Tris-HCI(pH 7.6), 100 mM NaCI, 7 mM MgCl2, 20 mM 2mercaptoethanol, and 100 mg/ml BSA. Plasmids containing the p-globin gene

(pHbps and pHbpA) were digested under the conditions described above with
only 1 hr incubation. Heating the reaction mixtures at 60 °C for 10 min
terminated all reactions.

Agarose Gel Electrophoresis and Hybridization. Plasmid and
genomic DNA samples digested with restriction enzymes were extracted with
phenol and chloroform before precipitation with cold ethanol. The DNA was
resuspended in 30 pi of 10 mM Tris-HCI pH 7.5, 1 mM EDTA,0.05%
bromphenol blue, 0.05% xylene cyanol, 3% Ficoll and the mixture was loaded

onto an 0.8% agarose gel. The the agarose gel was then subjected to
electrophoresis in TBE buffer for 7 hr at 60 V (TBE = 89 mM Tris-HCI, 89 mM

boric acid, 2 mM EDTA). At its completion the gel was dried down under
vacuum, and subsequently stained with ethidium bromide (0.5 pg/ml) and
photographed under UV illumination. Prior to hybridization, DNA in both the
electrophoresed and the in SilU dot gels were first denatured in 200 ml of 0.5 M

NaOH, 0.15 M NaCI at room temperature for 30 min and then neutralized with
200 ml of 0.5 M Tris-HCI[pH 8.0], 0.15 M NaCI for 20 min at room temperature.
The gels were hybridized to the appropriate labeled oligonucleotide
probes in 10 ml of 5X SSPE (IX SSPE = 10 mM sodium phosphate [pH 7.0],
0.18 M NaCI, and 1 mM EDTA), 0.1% SDS, 10 pg/ml of Homo-mix RNA, and

10® cpm/ml of labeled ollgonucleotide at 60 °C overnight. Hybridizations were
performed in "Seal-a-Meal" bags. At the completion of the hybridization, the
geis were removed and washed three times for 30 min each with 6X SSC (1X

SSC = 0.15 M NaCI, 0.015 M sodium citrate) at room temperature. Following a
subsequent wash with TMACI solution (TMACI = 50 mM Tris [pH 8.0], 3 M
tetramethylammonium chloride, 2 mM EDTA, 0.25% SDS) at 37 °C for 1 hr [76],
the gels were subjected to stringent washing at conditions described in the
figure legends and exposed to XAR-5 X-ray film (Kodak) at -70 °C for 1-3 days
with two Dupont Lightning-Plus intensifier screens.

I.2.b.

Methodologies Used In in Situ Dot Studies

Preparation of the la Situ Dot samples.

Agarose gels were

prepared by pouring 75 ml of melted 0.8% agarose into a 10 x 14 cm gel tray
followed by inserting the bottom of a Falcon 96-well flexible microtiter dish

(Falcon Micro Test III Flexible Assay Plate) as a "comb." Care was taken that
the microtitier plate wells did not touch the tray at the bottom of the gel. The gel
was allowed to solidify. DMA samples digested with restriction enzymes were
extracted with phenol and chloroform before being recovered by cold ethanol
precipitation. A 20 pi sample containing 2-5 pg of DNA, either intact or digested
with Pvu II, was mixed with 20 pi of 1.6% agarose at 65 °G. The hot mixture was
carefully pipetted into the circular wells in agarose gels. When all DNA samples
were applied and the agarose solidified, the gel was covered by a top layer (25

ml) of 0.8% agarose solution to embed the in silu dot samples. In the case of
RNA, 1 mg of total RNA in 20 pi of water was heated at 50 °C for 1 hr and
loaded into the depressions in the gel. After the sample was absorbed, the

wells were filled with 0.8% agarose at 65 °C and the entire gel was overlaid

with 25 ml of 0.8% agarose at 65 °C. The two layered gel was placed on

Whatman 3MM paper, covered with Saran Wrap, and dried under vacuum at
room temperature for 2-3 hr and then at 60 °C for 30 min. The dried gel was

soaked in water and used directly for hybridization with the 32p.iabeled 5'
phosphorylated oligonucleotides following denaturation in 200 ml of 0.5 N
NaOH, 0.15 M NaCI at room temperature for 30 min and reneutralization with
200 ml of 0.05 M Tris-HCI pH 8.0, 0.15 M NaCI solution at room temperature for

20 min as described previously by Miyada and Wallace [72].

I.2.C.

Methodologies used In Ligation Studies

Preparation of Plasmid and Genomic DNA Templates for

Ligation Studies. Plasmids pHjJA and pHpS contain a 4.4 Kbp normal (pA)

or sickle cell (pS) p-globin gene respectively inserted at the Pst I sites of
pBR322. Genomic DNA samples were collected and prepared as described

above. Prior to their use as templates in ligation reactions, both plasmid and
genomic DNA samples were treated with restriction enzymes followed by
digestion with Exo III. Plasmid DNA was digested with Bam HI (5 units/pmol.)
for 2 hr at 37 °C and terminated in a boiling water bath for 5 min. Subsequently,
the reaction was adjusted to 1 mM DTT and Exo III (100 units/pmol) added. The
reaction was incubated for 4 hr at 37 °C. Where indicated, genomic DNA (2-5

jxg) was digested with Tag I restriction enzyme (10 units/pg) overnight at 65 °C
and followed by Bam HI digestion (10 units/pg) for 8 hr at 37 °C. Exo III
digestion was then carried out at 100 units/pg for 5 hr. Phenol-chloroform
extraction was used for final purification of both plasmid and genomic DNA

template. Taq I( Boehrlnger Mannheim) digestions were carried out in 50 mM

Tris- HCI(pH 7.5), 10 mM MgC[2, 100 mM NaCI, 1 mM DTT and 100 pg/ml BSA.
Bam HI (Bethesda Research Laboratory) digestions were performed in reaction
mixtures containing 20 mM Tris HCI[pH 7.6], 100 mM NaCI, 7 mM MgCl2, 20
mM 2-mercaptoethanol, and 100 pg/ml BSA.

Oligonucleotide Ligation Reactions. All oligodeoxyribonucleotide
ligation reactions on oligonucleotide templates were carried out in 50 mM TrisHCI[pH 7.6], 10 mM MgCl2, 1 mM ATP, 1 mM DTT, and 5% PEG with 5-10 mM

each of substrate oligonucleotides mixed with a small amount of radioactively
labelled 3' oligonucleotide substrate (100,000 - 300,000 cpm) and the amount
of template indicated in the figure legends. Following 5-10 min of boiling, the
reaction mixtures containing plasmid or genomic DNA templates were cooled
on ice for 60 sec. Reactions were initiated with the addition of ligase (1 unit;
BRL). Unless otherwise indicated, all ligation reactions were carried out at 30

°C and were terminated by boiling for 5 min. A small aliquot of the reaction
mixture was then withdrawn for electrophoresis and optionally treated with calf
intestinal alkaline phosphatase (1-5 units) for 1-2 hr. The kinetic measurements
were made by withdrawing aliquots (3-5 pi) from a master reaction mixture at

predetermined incubation times and mixing the aliquots with 1 pi of a 200 mM
EDTA solution prior to heat inactivation of the enzymes.

Ligation Amplification Systems.

Unless otherwise stated, all

oligodeoxyribonucleotide ligation reactions were carried out in 50 mM Tris-HCI

[pH 7.6], 10 mM MgCl2.1 mM ATP, 1 mM DTT, 200 mM NaCI and 5% PEG with
5-10 pM each of substrate oligonucleotides mixed with small amount of

radioactively labelled 3' oligonucleotide substrate (100,000-300,000 cpm) and
the indicated amount of template. Reactions were initiated as previously stated

following 5-10 min of boiling and the addition of ligase (1 unit; BRL). All ligation
reactions were carried out at 30 °C for the specified incubation time and
terminated by heating to 100 °C for 5 min.

"Linear Amplification System"- In linear amplification of the ligation
product, the oligonucleotide, plasmid, or genomic DNA sample served as the

template throughout the amplification rounds. Linear amplifications involved

the use of an unlabeled substrate oligonucleotide set which is complementary
to the appropriate template (to the oligonucleotide template or to one strand of

the duplex plasmid or genomic DNA molecule)(Table 5). For example, either
the 0N1/0N2 or ON3/ON4 set may serve as substrates, but not both (see Fig.
5). Each round was initiated by the addition of ligase (1 unit) to the reaction

mixture. The reaction was then incubated at 30 °C for 30 min or longer in cases

of low template concentration. Each round was terminated by incubating in a
boiling water bath for 5 min. Before the next round, the reaction mixture was

centrifuged in Eppendorf table top centrifuge for 10 sec and cooled on ice.

After N rounds there was an N (1 +X)fold amplification of product, where X is the
efficiency of the ligation reaction. Following the final round of amplification, the

ligated product was then detected in a subsequent round of ligation. The
detection system employed the radioactively labeled counterpart substrate set.

For example, labeled ON3/ON4 set was used in the detection of the ligated
0N1-0N2 product, and vice versa (see Fig. 14). A small aliquot of the detection
mixture was then withdrawn for electrophoresis and optionally treated with calfintestinal alkaline phosphatase (1-5 units) for 1-2 hr.

"Exponential Amplification System"- Exponential amplifications of

ligation products were performed as described for the linear amplifications,
except both 0N1/0N2 and ON3/ON4 substrate sets were included in the

reaction. Since ligated products of either set can serve as a template for the
other, the template concentration of each round increased at an exponential

rate. After N rounds then, the product formation was equal to (1+Q)N-i where
Q is the ligation efficiency. For detection, radioactively labeled substrate was
included at the beginning or added before the final round.

Polymerase Chain Reaction generating p-giobin fragments.
Polymerase Chain Reaction primers, BGP1 and BGP2, are 19 base long
synthetic oligodeoxyribonucleotides which anneal to the p-globin gene at
positions 256 nucleotides apart [27]. One microgram samples of genomic DNA
samples were routinely used as templates in these reactions. Amplification

reactions were performed according to the instruction provided with the
Polymerase Chain Reaction Kit (Perkin-Elmer-Cetus) including 2.5 units of
Thermus aquaticus DNA polymerase {Tag polymerase) and 2.5 pM of
oligonucleotide primers. Thirty rounds of amplification gave approximately 5

XI05 fold of amplification. A 10 pi aliquot of the reaction mixture was
subsequently subjected to electrophoresis in 1.5 % agarose gel at 60 V for 5 hr

and transferred to a Genetran nylon membrane with 20 X SSC according to
Southern [77]. Likewise, 10 pi aliquots of the reaction mixture were used as
templates in the ligation detection systems.

Poiyacryiamide Gei Eiectrophoresis and Quantization. The
samples from ligation reactions were mixed with Ficoll-Loading Buffer and

subjected to electrophoresis in TBE on a 20% polyacrylamlde (Bio-Rad) urea

(7M) gel at 600 V for 1.5 hr. The gel was then wrapped in Saran Wrap and
autoradiographed between two Lightning-Plus intensifier screens (Dupont)
usually overnight. The ligation product and adenylate were quantitated either

by densitometric measurements of the autoradiograph or directly from the gel
using the AMBIS Radioisotope Scanning System II (Automated Microbiology
System, Inc.). With the latter, the polyacrylamlde gel was first fixed in a 5%
acetic acid solution for 10 min and neutralized in 6X SSC.

I.2.d.

Methodologies used In Allele Specific Polymerase Chain

Reactions

Aliele Specific Polymerase Chain Reaction. H(314A (5'-

GAGCTGACTCCTGA)and BGP2(S'-AATAGAGGAATAGGGAGAG)at
concentrations of 0.12 pM were used as the primer set for the amplification of

the normal p-globin gene (pA). Similarly 0.12 pM Hp14S (5'GAGGTGAGTGGTGT)and 0.12 pM BGP2 were used as the primer set for he
amplification of the sickle cell gene (pS). Both primer sets directed the
amplification of a 203 bp p-globin allele specific fragment. As an internal
positive control, all reactions contained an additional primer set for the human
growth hormone gene comprising of 0.2 pM each of GHPGR1 (5'-

TTGGGAAGGATTGGGTTA)and GHPGR 2(S'-GGATTTGTGTTGTGTTTG).

GHPGR1 and GHPGR2 direct the amplification of a 422 bp fragment of the
human growth hormone gene across exon 2, including sequences from intron 1

and 2. All reactions were performed in a volume of 50 pi containing 50 mM KGI,
10 mM Tris-HGI[pH 8.3], 1.5 mM MgGl2, 0.01% (wA/) gelatin, 0.5 pg/ml template

DNA,0.1 mM each of dATP. dCTP,dGTP, and TTP and 2.5 units of Taq

polymerase (Cetus). Reactions were carried out for 25 cycles at an annealing
temperature of 55 °C for 2 min, a polymerization temperature of 72 °C for 3 min
and a heat denaturation temperature of 94 °C for 1 min on a Perkin-Elmer-

Cetus DNA Thermal Cycler, At the end of the 25 rounds the samples were held
at 4 °C in the thermal cycler until removed for analysis.

Analysis of of the PGR products. An aliquot (15 pi) of each of the
completed reaction was mixed with 5 pi of 5 X Ficoll loading buffer(IX = 10 mM

Tris-HGI[pH 7.5], 1 mM EDTA,0.05% bromphenol blue, 0.05% xylene cyanol,
and 3% Ficoll), and subjected to electrophoresis in a 1,5% agarose gel,
Electrophoresis was performed in TBE buffer for 2 hr at 120 V, At the

completion of electrophoresis the gel was stained in 1,0 pg/ml ethidium
bromide for 15 min, destained in water for 10 min and photographed under
ultraviolet transillumination.

1.3

I.S.a.

RESULTS

Direct Analysis of Single Nucieotide Variation in Human DNA

and RNA Using in situ Dot Hybridization
Probe Design. A 23-nucleotide-long HLA B27 specific oligonucleotide
probe, complementary to a region of the ai-domain of the human major
histocompatibility complex class I antigen coding sequence, was synthesized
(Table 2). This region has been shown by sequence analysis to be unique to
HLA-B27 allele [33]. A comparison of the DNA sequence of the HLA-B27 allele
with that of B7 allele reveals differences at only two nucieotide positions. The
sequence variations in the homologous probe region between the B27 genetic
locus and other HLA Class I loci( HLA-A antigen and HLA-Cw3)are much
more pronounced. The HLA-B 27 probe is designed to maximize the
destabilizing effects of these sequence mismatches by centering them almost
equidistant from the ends of the duplex, thereby increasing the specificity of the
oligonucleotide probe for the HLA-B27 allele.

The two human |3-globin gene probes, HP23A' and HP23S', are both 23
bases long and specify the region of p-globin gene where the sickle cell point
mutation is located. Twenty three nucleotides is a sufficient probe length to
expect that the probe will recognize only the sequence of interest (i.e., locus
specific [81]). The sickle cell mutation is located in the center of the probe

sequence, again, to maximize destabilization. The HP23A' probe, which

hybridizes perfectly to normal p-globin DNA (pA), hybridizes to the sickle cell p-

globin DNA (pS) with a single mismatch. Likewise, HP23S' probe hybridizes
perfectly to the sickle cell allele DNA but hybridizes with a single mismatch to

* - Data from Szot et. al.(1986)
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Table 2.

mismatch to the normal allele DNA.

Specificity of the HLA-B27 Probe. The specificity of the HLA- B27
probe Is demonstrated In Fig. 1 for both electrophoresed gel samples and in silu

dot gel samples. At 65 °C the HLA-B27 probe specifically hybridized to a single
3.6-kb Pvu II fragment of the DNA from the HLA-B27 antigen-positive individual

(HM: HLA-B7/B27) but not to the DNA from an Individual that does not contain
the HLA-B27 allele (DW: HLA-B13/Bw60). When the same 23-nucleotlde-long
probe was used to probe in silu dot samples, each containing 2 pg of
undigested genomic DNA, a hybridization signal was seen only for the HM
(HLA-B27) DNA sample (Flg.1 right). The best results were obtained using a

tetramethylammonlum chloride wash [82]. The sharp temperature-specific
dissociation property of the ollgonucleotlde and DNA duplex In 3 M

tetramethylammonlum chloride [76] allowed extensive washing at 62 °C without
a significant loss of the specific signal Intensity. Stringent washing In 6X BSC
solution by the approach described previously [72], while achieving similar
discrimination between HLA-B27 and control DNA samples, resulted In a

greater loss of the HLA-B27 specific signal (results not shown).

Specificity of the p-Giobin Oiigonucieotide Probes. Plasmlds

pHpS and pHpA were digested with Bam H1 to produce a 1.8 Kbp DNA
fragment containing the region of the p-globin gene complementary to the
allele-speclfic probes (Table 3). The digested DNA was separated
electrophoretlcally on an agarose gel, denatured, and hybridized to the globlnspeclflc probes either In the presence or the absence of competitor probes. In

the absence of unlabeled HP23A', 32p.Hp23S' hybridized to both plasmlds.

Fig. 1. Hybridization of ^^P-iabeied HLA-B27 probe to genomic
DMA samples. 10 |ig of genomic DNA from a HLA-B27 positive individual

(HM: B7/B27) and a HLA-B7 negative individual (DW: B13/Bw60) were digested

with Pvu II and hybridized to 32p-iabeled HLA-B27 specific probe (left).
Stringent wash with TMACI solution was then applied twice at 60 °C for 30 min
and once at 62 °C for 1 hr. Identical stringent washes were used for in situ dot
gel samples in which 2 pg of uncut genomic DNA was mixed with 1.6 %
agarose and embedded in two 0.8 % agarose layers (right).
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Table

Genes

although the signal was more intense with the pHpS piasmid (Fig. 2). When a
10-fold molar excess of unlabeled competitor oligonucleotide probe (HP23A')

was included in the hybridization mixture, only the lane containing the pHpS
piasmid showed hybridization with the labeled Hp23S' probe. The opposite
result was also shown in Fig. 2 with labeled HP23A' oligonucleotide as probe
and unlabeled Hp23S' as competitor.

Hybridization of the p-giobin probes to total DMA.

Globin

oligonucleotide probes produced considerable nonspecific binding to high
molecular weight undigested genomic DMA (data not shown). In situ dot
samples, therefore, were prepared with DMA (5 pg) digested with Pvu II to

decrease the length of the DNA, and hybridized under competition conditions

(Fig. 3). Labeled HP23S' probes bound specifically to in situ dots containing
DNA from either sickle cell disease (homozygous) or sickle cell trait

(heterozygous) individuals, while HP23A' probe hybridized only to DNA from
heterozygous sickle cell and homozygous normal individuals. Note that the

signal obtained was higher with the HP23A' probe, presumably because this
probe had a higher specific activity than the Hp23S' probe. The p-thalassemia
DNA did not bind either probe. The genotypes of the individuals can be
interpreted from the diagnostic pattern of hybridization as shown in Table 4.
The quantitative aspects of the pattern of hybridization described in Table 4
were not observed in Fig. 3 perhaps because the amount of DNA present in
each of the Iq silu dots was not exactly the same.

Hybridization of RNA using in situ dots. RNA was isolated from

the blood cells of four individuals having different a- and p-globin genotypes:

Fig. 2. Competition hybridization of HP23A' and HP23S' probe to

pHpA and pHpS piasmids. Plasmids (0.1 ^ig) containing the normai pgiobin gene (pHpA) or sickle cell p-globin gene (pHpS) were digested with Bam
HI, producing a 1.8 Kbp DMA fragment containing the 5' end of p-globin gene
complementary to the probe. 5' -32p labeled HP23A' or HP23S' were used to
probe the plasmid samples either in the absence or in the presence of a 10-foId
molar excess of unlabeled HP23S' or HP23A', respectively, as competitors.
After washes in 6X SSC, the gels were washed with TMACI solution for 30 min
at 62 °C.
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Fig. 3. Competition hybridization of HP23A' and HP23S' probes to
in situ dot genomic DNA samples. Genomic DNA (approximately 5 pg)
from normal (AA), homozygous sickle cell (SS), sickle cell trait (AS) and p-

thalassemia (pTh/pTh) dcncrs was digested with Pvu II and applied tc an in situ
dot gel. Plasmid DNA containing the normal p-glcbin gene (60 pg) mixed with 5

pg of p-thalassemia DNA was used in the control (pHpA). The gels were
hybridized with either 5'-32p labeled HPS23' or HPA23' in the presence of 10fcld molar excess of unlabeled HPA23' or HpS23', respectively. Subsequent tc
competition hybridization and non-stringent wash, the in situ dots were
subjected tc stringent wash three times for 30 min at 62 °C.

probe: H|323A' HP23S'
r:

(-) lack of tiybridization.

aileief and aliele 2, respectively. (+) Hybridization;

P1 and p2 are allele-specific oligonucleotide probes specific for

Probe

Genotype( alleles 1 and 2)

Pattern of Hybridization of
Aiieie-Specific Probe to immobilized DNA

Table 4.

one homozygous normal (P^/pA)^ one homozygous sickle cell (p^/pS), one with
sickle cell trait (pA/pS) with a-thalassemia, and one with sickle cell trait without
a-thalassemia. As shown in Fig. 4 the Hpi9A' probe only hybridized with the
RNA derived from the normal and heterozygous individuals while the Hpi9S'
probe hybridized with the RNA derived from heterozygous and sickle cell

anemia individuals. No differences were observed in the ratios of pA and pS
mRNA in the sickle cell trait individuals regardless the presence of the athalassemia allele. This result is consistent with a previous report [83].

I.S.b. Ligation Amplification Reaction I: Specificity of the nickclosing activity of bacteriophage T4 DNA iigase

Substrate Oiigonucleotide Design. The substrate oligonucleotide
pairs in the ligation studies (8 and 14 nucleotides long) were designed to be
complementary to the p-globin gene surrounding the sickle cell mutation on

either strand (Figure 5). 0N1/0NS2 and ON1/ONA2 pairs are both
complementary to the coding strand, 0NS2 and 0NA2 differ by a single
nucleotide at the 5' end of the oligonucleotide. The 5' nucleotide of 0NS2 is
complementary to the mutated A residue of sickle cell anemia while the 5'
nucleotide of 0NA2 is complementary to the T residue at that position in the
normal gene (Table 5). Similarly, the ONS3/ON4 and ONS3/ON4 pairs are

complementary to the noncoding strand and 0NS3 and 0NA3 differ by a single
nucleotide at their 3' ends.

In the human genome (3 x lO^ base-pairs), an octamer would be
expected to be complementary to some 10"^ sites, assuming complete
randomness of the genomic sequence [81]. Given the same assumption, a

Fig. 4. Hybridization of Hpi9A' and Hpi9S' to in situ dot gels
containing RNA from individuals with different a- and p-globin
genotypes. RNA (1 |ig) from individuals was immobilized in agarose as
described in Materials and Methods. The gel was hybridized with labeled

Hpi9A' (3X10® cpm/ml) in the presence of a 10-fold molar excess of
unlabeled HpiSS*. The gel was washed three times for 15 min each in 6 X

SSC at room temperature, followed by a wash for 1 min at 60 °C in the same
buffer and exposed to Kodak X-AR film with two Dupont Lightning-Plus

intensifier screens overnight. After removing the probe, the gel was hybridized
with labeled Hpi9S' in the presence of a 10-fold molar excess of unlabeled

Hpi9A' and washed and exposed in the same way. AA, RNA from an individual
homozygous for the normal p-globin gene; SS, RNA from an individual with
sickle cell anemia; AS + a-thal, RNA from an individual with sickle cell trait and

a-thalassemia (a-globin genotype -a/-a); AS, RNA from an individual with sickle
cell trait but without additional a-thalassemia.

probe:
Hp19S'

Hp19A'

•AS
AS+athal

SS

>T)transversion mutation occurs.

0NA3(5' CACCTGACTCCTGA)or 0NS3(5' CAGGTGACTCCTGT)]and 0N4(5' GGAGAAGT)are
complementary to the noncoding (-) strand in the boxed region. 0NA3, like 0NA2, is completely
complementary to the pA gene and 0NS3 is completely complementary to the pS allele. The 3' nucleotide
of 0NS3 forms a T-T mismatch with pA allele (see Table 5). The ligation junctions of adjacent 0N1/0N2
and ON3/ON4 substrates are directly over the base pair of interest {*), the position which the sickle cell (A~

(pS). The 5' nucleotide of the 0NS2 forms an A-A mismatch with the pA allele (see Table 5). 0N3[either

Fig. 5. Annealing regions of ollgonucleotlde substrates on normal human p-globin gene.
The sequence of the region of the normal human p-globin gene (pA) to which the oligonucleotide substrate
are complementary is shown. 0N1 (5'-CGGCAGACTTCTCC)and 0N2[either 0NA2(5' TCAGGAGT)or
0NS2(5'-ACAGGAGT)] are complementary to the coding (+)strand in the boxed region. 0NA2 is
completely complementary to the sequence shown and 0NS2 is complementary to the sickle-cell allele

0N3

0N4

(-)3'... C|GTGGACTGAGGACT|CCTCTT^GACGGC A ... 5'

0N2
ONI
(+)5'...GCACCTG|ACTCCTG AlGGAG AAGTCTGCCGIt ... 3'

pA and pS
pA
pA
pS
ps
pA
ps
pA and pS
pA and ps
pA
ps
pA
ps

Gene"

GGGGAGAGTTGTGGAGAGGAGTG

GGGGAGAGTTGTGGTGAGGAGTG

GTGGTGTGGAGAAGTGTGG

GTGGTGAGGAGAAGTGTGG

GGAGGA

GGAGAAGT

GAGGTGAGTGGTGT

GAGCTGACTCCTGA

ACAGGA

ACAGGAGT

TCAGGA

TOAGGAGT

CGGCAGACTTCTCC

Sequence (5'—>3')c

shown in Fig. 1.

c. Ollgonucleotldes are complementary to the indicated gene in the regions

p-globin gene(pA)or to the sickle cell b-globin gene (pS).

b. Ttie ollgonucleotldes are perfectly complementary to the normal human

a. Oligonucleotide designations. For an explanation see Fig. 1.

Hp23S'

HP23A'

HP19A
Hp19S

0N4*

0N4

0NS3

0NA3

0NS2*

0NS2

0NA2*

0NA2

0N1

Oligonucleotide a

Synthetic oligonucleotide substrated and templates

Nucleotlde Sequence of

Table 5

tetradecamer would be present approximately ten times. However, the
probability of more than a single occurrence of an octamer and a tetradecamer

adjacent to each other is extremely low [18]. Under appropriate conditions then,

the ligation would only be expected to take place at a single, specific genomic
site generating a ligation product of 22 nucleotides in length.
H(319S and Hpi9A are both unique nonadecamers that are
complementary to the noncoding strand of the p-globin gene. They can serve as

oligonucleotide templates for ligation of the 0N1/0N2 pairs. Hp23S' and
HP23A' are both 23 nucleotides in length and are complementary to the coding
strand of p-globin gene. They can serve as templates for the ligation of the
ON3/ON4 pairs.

Sequence Specific Ligation T4 DNA ligase effectively ligates
0N1/0NS2 and ONS3/ON4 pairs on theappropriate oligonucleotide templates,
Hpi9S and HP23S', respectively. The 22-base-long product of these reactions

contains an internal 32p-iabelled phosphodiester bond formed by the joining of

32p-5'-phosphorylated octamer substrate with the non-phosphorylated
tetradecamer substrate. The ligation product was separated from the labeled
octamer substrates by electrophoresis on a 7 M urea, 20% polyacrylamide gel
(Fig. 6, lanes c and i). The internal phosphate was resistant to calf-intestinal

alkaline phosphatase (CIAP), which efficiently removes the 5'-phosphate from
the labeled octamer substrate (lanes e and k). When incorrect templates

(Hp19A and HP23A) were used for ligation, significantly less ligation product
was produced (lanes d and j). Mismatch ligation is 4-5 times greater for

ONS3/ON4 (lane j) than for 0N1/0NS2(lane d) as measured by appearance of
the inappropriate product. Controls which lack of either the template or ligase

Fig. 6. Ligation of ollgonucleotide substrates on oligonucleotide

templates. 10 pmoles of 32p.5' phosphorylated 0NS2 and unlabeled 5' OH0N1 (a-f) or 32p-5' phosphorylated 0N4 and unlabeled 5'0H-0NS3 (g-l) were
llgated on 19-nucleotide-long or 21-nucleotlde-long ollgonucleotide templates,
respectively, at 30 °C for 30 min with 1 unit of T4 DNA ligase in 10 pi of total
reaction volume. Ligation of the oligonucleotide substrates was carried out in

50 mM Tris-HCI(pH 7.6), 10 mM MgCl2,1 mM ATP, 1 mM DTT and 5% PEG.
Lanes a and g, without enzyme, and lanes b and h, without template, are
negative controls. Oligonucleotide template (1 pmole) was used in each

reaction: Hpi9S (lane c), Hpi9A (lane d), HP23S'(lane i), and HP23A'(lane j).
Hpi9S is a 19-nucleotide-long oligonucleotide template whose sequence is
entirely complementary to 0N1/0NS2 substrate pair. HP23S' is a 23nucleotide-long oligonucleotide template that is perfectly complementary to

ONS3/ON4 substrate pair. Hpi9A and HP23A' are single nucleotide variants of
these templates, creating a single base pair mismatch at the ligation junction
with 0N1/0NS2 and ONS3/ON4 substrate sets, respectively. Samples of 5 pi
from lanes c, d, i, and j were withdrawn after heat inactivation and treated with

10 units of calf-intestinal alkaline phosphatase for 2 hrs before electrophoresis
(designated as lanes e, f, k, and I, respectively). Autoradiography of the
polyacrylamide gel was allowed to take place for 16 hr with 2 intensifier
screens.
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showed that these two components were required for the reaction (lanes a, b,
g, and h). Similar results were obtained for the ligation of 0N1/0NA2 and

ONA3/ON4 pairs on appropriate templates (results not shown).

Time Course of Oligonucieotlde Ligation. At 30 °C and a
template concentration of 1 GO nM, the formation of the 22-nucleotide-long
ligation product appeared with the time course depicted in Fig. 7. The reaction
was one-half complete in approximately 3 min. The product saturated all of the
available template and further incubation did not increase the amount of

product. Once formed, the 22-nucleotide-long product remained stably bound

to the template, thus restricting the template from annealing to other substrates.
The reaction is therefore limited by the DNA template and not the
oligonucieotlde substrates.

Kinetics and Temperature Dependence of oiigonucieotide
iigation in the presence and absence of NaCi. The temperature

dependence of the oligonucieotlde ligation reaction appears to be biphasic with

optimal temperatures occurring at 28 °C and 37 °C (Fig. 8). The biphasic nature
of the reaction was not influenced by the absence or presence of 200 mM NaCI
in the reaction mixture. NaCI (200 mM)did, however, alter the kinetics of the
ligation reaction. NaCI acts as an nonclassical noncompetitive inhibitor greatly
reducing the Vmax while slightly increasing the Km (Fig. 9). The apparent Km
for the oligonucieotlde template in the absence of salt was 0.05 pM, whereas the

Km increased to 0.2 pM in the presence of 200 mM NaCI. The Vmax of the

ligation reaction was reduced by approximately 30-fold in the presence of 200
mM NaCI.

Fig. 7. Time course of oligonucleotlde llgation reaction on
oiigonucieotide tempiates. 1 jiM 32p.5' labeled 0NA2 and unlabeled ONI
were llgated on 100 nM of Hpi9A template. At various reaction time interval, 4
pi aliquots were withdrawn from the master reaction mixture and mixed with Ipl
of 200 mM EDTA solution before heat inactivation at 100 °C for 5 min. Results

are expressed as a fraction of the final amount of product observed after 30 min
at 30 °C.

Fig. 8. Temperature dependence of oligonucleotlde ligation

reaction. Samples of 32p phosphorylated 0NA2 and unlabeled 0N1 (10
pmoles each) were llgated on 1 pmole of Hpi9A template with 1 unit of T4 DNA
ligase at various reaction temperatures for 10 min each. After heat inactivation,
the ligation products were quantitated by densitometric measurement of a 16 hr
autoradiograph of the 20% denaturing polyacrylamide gel. Results are
expressed as fractions of the products formed at 30 °C. The experiments was
performed either in the presence (•) or in the absence (O) of 200 mM NaCI using
the same reaction buffer as described in Fig. 6.
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Fig. 9. Effect of salt on the kinetics of T4 DNA llgase
ollgonucleotlde reaction. The master assay mixture consists 1.25 mM of
each substrate (unlabeled 0NA3 and labeled 0N4)and 10-250 nM of H|323A'

as template. 200 mM EDTA and subsequent heat inactivatlon were used to
terminate an aliquot of reaction mixture at various times. The samples were

processed as described in the Methods section. Following electrophoresis the
20 % polyacrylamide (7M urea) was soaked in 5% acetic acid for 10 min. The
amount of 22-nucleotide-long ligation product was quantitated using an Ambis
Radioisotope Scanning System II. Initial velocity was calculated either by

plotting the time course or estimating reaction time required to complete 50% of
product formation. Double reciprocal plot (1A/ vs 1/S) was drawn for
ollgonucleotlde reaction in the presence (•) or in the absence (o) of 200 mM
NaCI.
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Accumulation of 5' adenyiates under mismatched conditions.
The 5' adenylate of the 3' oligonucleotide substrate is a normal intermediate of
the ligation reaction formed by the transfer of the adenyiate from the enzymeadenylate complex to the 5' phosphoryl group of the 3' substrate, in the
presence of the mismatched template, the formation of the phosphodiester
bond between the octamer substrate and the tetradecamer substrate did not

proceed readily; hence the adenylated octamer substrate dissociated from the

template and steadily accumulated in the reaction given enough kinetic energy
for dissociation. At 30 °C, this accumulation took place since the temperature

exceeded the empirical dissociation temperature (Td) of 24 °C for an 8nucleotide-long oligonucleotide containing 50% GC residues [72](Fig. 10,
lanes d to h). The 5' adenyiates were also resistant to calf-intestinal alkaline

phosphatase and it had a slightly lower electrophoretic mobility than the
octamer precursor (Fig. 10, lane i).

Effects of NaCi and spermidine on mismatch iigation and
adenyiate formation. The specificity of T4 DNA ligase for the

oligonucleotide substrates was measured by the amount of matched ligation
relative to the amount of mismatched ligation in the presence of 100 nM of

template at 30 °C with one unit of enzyme (Table 6 and Fig.11). These
specificity ratios were 6 and 1.5, respectively, for 0N1/0NA2 and ONA3/ON4
pairs. NaCI at 200 mM concentration, however, enhanced the specificity of the
ligation reaction by some 10 to 26 fold. In addition to mismatch ligation, 200
mM NaCI suppressed the formation of 5' adenyiates (Fig. 11, lanes c and f).

Spermidine, a polyamine, exerted similar effect on the ligation reaction. Both
mismatch product and adenyiate formation were suppressed by 60% as the

intervals, 1 min (lane d), 2 min (lane e), 5 min (lane f), 10 min (lane g), and 30 min (lane h), at 30 °C before
termination with EDTA and heating to 100 ®C for 5 min. An aliquot of the 30 min reaction mixture was
digested with 5 units of calf-intestinal alkaline phosphatase (lane i). Lanes a-c represent controls with no
enzyme , no template and the absence of ONI, respectively. Each control sample was incubated for 30
min. The 5' adenylate was identified by its resistance to CIAP digestion, its slower gel mobility and its
labeling with [a-32p] ATP (not shown).

labeled 0NS2 and unlabeled ONI were incubated in the presence of 50 nM Hpi9A for various time

Fig. 10. Formation of 5' adenylate in the presence of mismatched template. 2 mM 32p.5'
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Fig. 11. Effect of 200 mM NaCI on llgatlon product formation. 10
pmoles of substrate pairs 5'-0H-0N1 and 32p-5'-iabel0d 0NS2 (lanes a-c) and

5'-OH-ONS3 and 32p-5'-iabeled 0N4(lanes d-e) were ligated with 1 unit of T4
DNA ligase in the absence of template (lanes a and d), in the presence of ICQ
nM of Hpi9S (lane b), Hpi9A (lane c), Hp23S'(lane e), or HP23A'(lane f) as
template. 200 mM NaCI was either included (A) or excluded (B) in the reaction
mixture.
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200 mM NaCI

Specificity'^

Fold Increase^

a. - See Results and Discussion and Fig. 5 for tfie description of the oligonucleotide substrate
sets and Tabie 5 for their sequence.
b. - Specificity is defined as the ratio of ligation product formed in the presence of matched vs.
mismatched tenplate (100 nM) at 30 °C with one unit of enzyme, ten pnwl of each
substrate was used in a 10 ml reaction mixture containing 50 mM Tris-HCI(pH 7.6), 10 mM
MgCi2,1 mM ATP, 1 mM DTI and 5% PEG. The product formation (22-nucleotide-iong) was
anaiyzed using a 7 M urea/20% poiyacrylamide gel and quantitated by desitometric analysis
of the 16 h. autoradiogram.
c. - increase in specificity in the presence of 200 mM NaCI.

ONA3/ON4

0N1/0NA2

Oligonucleotide Substrate®

Specificity of T4 DNA iigase for 0N1/0NA2 and ONA3/ON4
in the presence and absense of NaCi

Table 6

spermidine concentration was Increased from 0 to 5 mM (Fig. 12). Furthermore,
the levels of mismatch ligation product and the adenylate correlated closely with
one another.

Genomic and Plasmid DNA as Templates for Oligonucleotide
pair ligation. For ligation reactions which involved genomic and plasmid

DNA templates, oligonucleotide substrate annealing sites were exposed by first
treating them with restriction enzymes {Bam HI with or without Taq^) and then
removing one strand using Exo III nuclease. Genomic DNA samples, p-

thalassemia

sickle cell (pS/pS), and normal (P^/pA), were treated in

this manner before serving as templates for ligation of 0N1/0NS2 and
ONS3/ON4 pairs (Fig. 13). To achieve amplification of the ligated product, the
ligation reaction was repeated three times by sequential rounds of heat
denaturation followed by the addition of more ligase. Only the sickle cell DNA
sample allowed the ligation of 0N1/0NS2, confirming the specificity of the

ligation reaction even on genomic template (Fig. 13, lane b). Plasmid DNA
samples treated with restriction enzyme and Exo III serve equally well as
templates for ligation (results not shown).

I.3.C. Ligation Ampiification Reaction if: Ampiification of specific
DNA sequences using sequentiai rounds of tempiate-dependent
iigation

Design of Substrate Oiigonucieotides and the Ligation

Ampiification System. The substrate oligonucleotide pairs used in the
ligation studies (octamer and tetradecamer) are substrates for the template

Fig.12. Effect of spermidlne on mismatch iigation product and 5'
adenyiate formation. Ligation assays were performed in 50 mM Tris HCI
[pH 7.6], 10 mM MgCl2, 1 mM ATP, 1 mM DTT and 5% PEG with 1 pmole of
Hp23A' and 10 pmoles each of 5'-0H-0N1 and 32p-5'.|abeied 0NS2 in 10 ml
reaction volume. Spermidlne was included at the concentrations indicated.
The reactions were carried for 15 min before heat inactivation. Mismatched

ligation product (o) and 5' adenyiate (•)formation were both quantitated by
densitometric measurements of 16 hr autoradiographs. Results are expressed
as fractions of product formation of the no spermidlne control.

O mismatch llgcticn
•5' adenylate
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SPERMIDINE CONCENTRATION (mM)

Fig. 13. Detection of llgation products on genomic DNA template. 5
|ig of p-thalassemia (lane a), sickle cell (lane b) or normal (lane c) genomic
DNA sample was digested with Bam H^/Taq 1 and Exo III nuclease as

described In the Methods section. 32p.5'.|a5eled 0NS2(100 fmol) was used
directly from T4 kinase labeling reaction without further purification by DE-52
chromatography. The 32p.|abeled-ONS2 was combined with 100 fmoles of
ONI and the appropriate templates In the presence of 200 mM NaCI and 0.5
unit of T4 DNA llgase. Total reaction volume was 10 pi. After 3 hr of Incubation
at 30 °C the reaction was terminated by boiling and a second round of llgation
was Initiated by adding another 0.5 unit of enzyme. The reaction was again
allowed to proceed for 3 hr. Three rounds of product enrichment was performed
for genomic DNA samples (a-c). Positive controls were performed with 0.01
(lane d), 1 (lane e), and 10 (lane f) fmoles of Hp19S and only 3 hr of Incubation.
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dependent ligation by T4 DNA ligase (Table 5). They are complementary to the
human p-globin gene in the region encompassing the position of the sickle cell

mutation on either strand (discussed above in Ligation Amplification Reaction i).
The two oligonucleotides in each pair anneal to the p-globin template at
adjacent positions such that 3' end of one oligonucleotide (ONI, DMAS, or
0NS3)and the 5' end of the other(0NA2,0NS2, or 0N4)form a ligatable
junction (Fig. 5). In this design, the site of the DNA sequence variation basepairs with either the 3' end nucleotide or the 5' end nucleotide of the substrate
depending on which strand,(+)or (-), serves as the template for ligation.
0N1/0NS2 and 0N1/0NA2 pairs both hybridize to the coding strand. 0NS2
and 0NA2 differ from each other by a single nucleotide at the 5' end with 0NS2

complementary to the sickle cell allele and 0NA2 to the normal allele (Table 5).
Similarly, ONS3/ON4 and ONA3/ON4 pairs hybridize to the noncoding strand
with 0NS3 and ONA3 differing by a single nucleotide at their 3' ends.

For the detection of either the pA or the pS alleles, either one pair of
oligonucleotide substrates for linear amplification or a set of 2 pairs of
oligonucleotide substrates for exponential amplification were utilized (see

below). 0N1/0NA2 and ONA3/ON4 constitute the substrate set for the normal
P-globin sequence while 0N1/0NS2 and ONS3/ON4 are the substrate set for
the sickle cell sequence. The specificity of this reaction depends entirely upon

the specificity of T4 ligase. Under appropriate conditions, a single base-pair
mismatch between the substrate and the template at the substrate pair junction

prevented their ligation. This feature was demonstrated in detail above.
In the exponential amplification scheme, template dependent ligation of
either 0N1/0N2 or ON3/ON4 pairs forms a 22-base-long product whose

sequence is complementary to the other substrate pair. For example, 0N1-

0NA2 product would be complementary to ONA3/ON4 substrate pair and
ONS3-ON4 product likewise would be complementary to 0N1/0NS2 substrate
pair. The products then could serve as template for the ligation of the
complementary substrate pair producing additional templates for further ligation
(Fig. 14). Once the 22-nucleotide-long product is formed as result of ligation, it
stays hybridized to its template. Heat denaturation is required to dissociate the

duplex. Heating the reaction mixture also inactivates the ligase. Subsequent
addition of fresh enzyme is therefore necessary to initiate the next round of
amplification. In N rounds, the amount of 22 base-long product would increase

in an exponential rate according to the equation,(1 + Q)N-f, where Q is the
ligation efficiency. Q ranges from 0 to 1.

Sequence Specific Ligation. The previous results section

demonstrated that a single base-pair mismatch between the template and the
substrate oligonucleotide reduced the efficiency of ligating the octamer and
tetradecamer substrates pairs. If a hexamer was used instead of the octamer

oligonucleotide as the 3' substrate, enzyme discrimination of the match and

mismatch nucleotide base-pair was even more pronounced (Fig. 15, compare
lanes c, d, g, and h). Little or no ligation took place under mismatched
conditions (Fig. 15, lanes d and h).

Second Strand Ligation. We tested whether the ligation product can
serve as the template for joining of additional substrates. Unlabeled 5'

phosphoryl 0NS2(octamer) or 0NS2*(hexamer) was ligated with ONI on the

Hp19S oligonucleotide template. Included in the mixture were equal molar
quantities of 0NS3 and either radioactively labeled 5' 32p-ON4 (octamer) or

Fig. 14. Ligation Amplification Scheme
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21-nucleotide-long oligonucleotide template respectively at 30 ®C for 30 min with 1 unit of T4 DNA ligase
in 10 ml of reaction volume. Samples a and e, without enzyme, and samples b and f, without template,
were the negative controls. Oligonucleotide templates (1 pmol) were used: Hp19S (c), Hpi9A (d), Hp23S'

pmoles of 32p.5' phosphorylated 0NS2* (hexamer) and uniabled 5' 0H-0N1 (a-d) or 32p-5'
phosphorylated 0N4* (hexamer) and unlabeled 5' 0H-0NS3 (e-h) were ligated on 19-nucleotid0-long or

Fig.15. Ligation of 0N1/0NS2* and 0NS3/ 0N4* pairs on ollgonucleotlde templates. Ten

IK

ON4*(hexamer). After 1 hr of incubation at 30 °C, 22- or 20- base-long 0N10N2 product formed as the reaction reached completion. The reaction mixtures
were then heated to dissociate the ligation product, freeing it to participate as
the template for the ligation of labeled ON3/ON4 pairs. The reaction mixture
was rapidly cooled and a second round of ligation was carried out after the

addition of fresh enzyme. The time course of the second strand ligation is

depicted in Fig. 16. At 30 °C, the 3' octamer substrate joined with the

tetradecamer to form the 22-nucleotide-long product. This 22-nucleotide-long
product formed during the first round served effectively as template for further

ligation. However, the 20-nucleotide-long ligation product resulting from the

hexamer and the tetradecamer substrates did not serve as template for the
second strand ligation at 30 °C. Lowering the reaction temperature to 15 °C did

allowed the formation of the second strand 20-nucleotide-long product at a very
slow rate compared to the second strand ligation of the octamer and the
tetradecamer at 30 °C.

Suppression of Blunt End Ligation. If allowed to anneal in

solution, a mixture of ONI,0N2,0N3, and 0N4 would form two partial

duplexes, ONI annealing to 0N4 and 0N2 annealing to 0N3. These duplexes
possess a phosphorylated blunt end that could be ligated to another blunt end

to form a product even in the absence of a template [45, 84]. Of the four

possible blunt end ligation products two are indistinguishable from the products
which are expected when a complementary template is present and thus
represent a potential source of a false positive test result if not suppressed. It is

quite clear from the amplification scheme that the initial rounds were quite
important, because the slightest amount of template independent ligation

Fig. 16. Usability of oiigonucieotide ligation product as template

for subsequent oiigonucieotide ligation. Ten pmoles each of 32p.5'
labeled 0NS2(A), 0NS2* (o,#) unlabeled 5' phosphorylated 0N4, 5'-0H-0N1
and 5'-OH-ONS3 were first incubated at 30 °C in the presence of 1 pmole of
H|323S' and 200 mM NaCI for 2 hr with 1 unit of T4 DNA ligase. The 20 |il of
reaction was terminated by heating at 100 °C for 5 min. The mixture was

centrifuged on Eppendorf desk top centrifuge for 10 sec and allowed to cool on
ice for 1 min. 1 unit of T4 ligase was added to initiate further ligation at either 30
°C (A,#) or 15 °C (o)for the indicated time period. Labeled products were
analyzed as described in Methods Section following a second round of heat
inactivation. Results are calculated according to the fraction of final product
level after 18 hr of incubation.
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product would be amplified to become a significant component of the final
signal.

Blunt end ligation was easily tested in our system by excluding template
from a typical ligation reaction in which all four substrates were present. In one
hr, a detectable level of blunt end product formed in a reaction mixture without
PEG (Fig. 17; control). If 5% PEG was included, 6 fold greater blunt end

products accumulated in the same length of time. Both NaCI and Pi were both
effective in suppressing undesirable blunt end ligation [85]. NaCI or Pi at above
200 mM completely inhibited blunt end ligation even in the presence of 5%
PEG. Because Pi is a more potent inhibitor of T4 DNA ligase than NaCI
(unpublished), we decided to include 200 mM NaCI rather than Pi in the
amplification reactions.

Efficiency of Ligation Ampiification. Fig. 18 depicts ligation
amplification reactions using the four oligonucleotide substrates designed to

detect the sickle cell allele of the |3-globin gene. Through 6 rounds, the ligation
reaction was specific for the HP23S'template containing the sickle cell

sequence. Products of the ligation increased with each round. The 22
nucleotide-long product would be expected tp increase in an exponentiai rate

according to the equation,(1 + Q)'^-"', where Q is the ligation efficiency.
Amplification was, in fact, exponential as shown by the linear relationship

between the logarithm of amplification versus round of ligation (Fig. 18, panel
B). The calculated efficiency Q was 0.98 which means that ligation occurred
with nearly perfect efficiency in every round.

Fig. 17. Blunt end product formation. 10 pmoles of substrate 5'-[32p]
labeled 0NS2: 5'-[^^P] labeled 0N4, 5'-0H-0N1 and 5'-OH-ONS3 were
incubated without template at 30 °C for 2 hrs In the presence of NaCI, PI,
polyethyleneglycol(PEG) or a combination of these. Results are expressed In
terms of relative product formed with respect to the amount of llgatlon product
detectable In the absence of NaCI, PI, or PEG (control).

Fig. 18. Exponential Ampiification of ligation product. (A) 6.67 nM of
oligonucleotide template, HP23S' or HP23A', was detected with ollgonucleotide

ligation substrate set; 1.33 pM each 5'-[32p] labeled 0NS2(lO^cpm ), 5'-[32p]
labeled 0N4(lO® cpm), 5' 0H-0N1 and 5'0H-0NS3. The products were
amplified through 6 rounds as described in the Methods. (B) Plot of logarithm
of amplification fold vs. round number. Amplification folds were determined by
relative product formed in each round with respect to product level in round 1.
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Ligation Amplification on Genomic and Plasmid Tempiates.
We previously demonstrated the ability of plasmid and genomic DNA to serve
as templates for oligonucleotide ligation (see above). Once the oligonucleotide
substrates were ligated on the plasmid or genomic DNA p-globin sequence
exposed by restriction enzyme and Exo III, the products were then amplified in
the reaction through multiple rounds. For reactions containing 10 nM plasmid

template, at least 10 rounds were necessary for the generation of detectable
signal in our system. The signal was highly specific. Only plasmid templates

bearing the sickle cell sequence, pHpS showed positive ligation product in 1216 rounds of amplification (Fig. 19 ; lanes d-f). No detectable ligation was noted

when pHpA plasmid containing the normal p-globin sequence was used ( lanes
g-i) or when template DNA was omitted (lanes a-c). The requirement for 10
rounds to achieve approximately 50 fold amplification did surprise us, since
only 3-6 rounds were needed for oligonucleotide template of the same
concentration.

Five micrograms of genomic DNA contains approximately 500,000

molecules of a homozygous single-copy gene. When used as a template in a

200 ml reaction mixture, a single-copy gene will have the concentration of 2.5 X

10-""^ M. Since this concentration is well below the apparent Km of T4 DNA
ligase for ligation template, it is expected that the enzyme activity would be
slowed considerably.

We attempted to overcome this kinetic constraint by

allowing early rounds of the ligation to incubate for a longer time. The ligation

time for initial rounds was 5 hours. With subsequent rounds, this time was
gradually reduced to 30 minutes.(Rounds 1-5 = 5 hr; rounds 6-10 = 4 hr; rounds
11-15 = 3 hr; rounds 16-20 = 2 hr; rounds 20-30 = 1 hr; and rounds 30+ = 30

min) Each round however was never allowed to exceed 5 hr in order to avoid

ligation substrate set (see Fig. 6 legend) in 100 pi of total volume. At 10th (a, d, g), 12th (b, e, h) and 14th
(c, f, i) rounds, a 4 pi aliquot was withdrawn from the reaction mix and analyzed accordingly.

described in Methods before serving as template for ligation amplification. No template (a-c), 1 nM PHpS
plasmid template (d-f), or 1 nM PHpA plasmid template (g-i) was amplified with 500 nM each of the

Fig. 19. LIgatlon amplification of plasmid DNA templates. Plasmid DNA was treated as
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accumulation of blunt end products. Fig. 20 depicts the template specific
ligation amplification on genomic DNA samples in 60-70 rounds (panel A lanes
c and d; panel B lanes e and f). Thalassemia DNA and mismatched genomic
DNA both did not produce a signal (lanes a and b and lanes e and f,
respectively).

Ligation Ampiification as a Detection Method for Polymerase
Chain Reaction Enriched Sequence. Using two 19 base-iongoiigonucleotide primers (BGP1 and BGP2) specific for the p-globin gene, 30
rounds of PGR performed on genomic DNA samples with Taq polymerase

amplified a 294 base pair fragment of p-giobin gene by approximately 500,000
fold (Fig. 21; Panel A lanes c-e). The same treatment of thalassemia DNA

(Panel A lane b) amplified a nonspecific sequence but the 294 base-pair band
was not produced. Allele specific oligonucleotide hybridization analysis of the
PGR enriched samples immobilized on a nylon filter confirmed that the enriched
DNA indeed contained the p-globin sequence of interest. Gompetition
hybridization of the filter with either radioactively labelied Hpi9S and uniabeied
Hpi9A or labelled Hpi9A and uniabeied Hpi9S correctly identified sickie cell

disease( pS/pS; Panel B , lane 2), normal p-globin( pA/pA; lane 3), and sickle
cell trait( pA/pS; lane 4) DNA.
The PGR enriched 294 base-pair fragments are ideal templates for LAR

analysis since they are relativeiy short in length and abundant enough to
overcome the ligase kinetic constraints. Ligation ampiification performed on
these 294 base-pair tempiates with ONI,0NS2,0NS3, and 0N4 showed

positive ligation for sickle cell disease and sickle cell trait samples (Panel G
lanes b and d). Ligation amplifications with ONI,0NA2,0NA3, and 0N4 were

Fig. 20. Ligation amplification of human genomic DNA samples.
Genomic DNA (5 ^ig) from p-thalassemia (a, b), sickle cell (c, d) and normal (e, f)

DNA were amplified in 200 nM pS ijgaticn substrate set. (A) or pA ligation
substrate set(B)(see Methods). 70(a, c, e) and 75(b, d, f) rounds are required
to achieve a detectable signal.
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sickle cell disease; e, g, normal; d, h, heterozygous sickle cell trait.

substrate set (a-d) or 200 nM pA detection substrate set (e-h) in 100 pi of total reaction volume. 50 pi from
each sample was analyzed by 20% polyacrylamide electrophoresis. a, e, p-thalassemia; b, f, homozygous

performed on 20 pi samples of PGR enriched sequences for 4 rounds with either 200 nM pS detection

sickle cell disease; 3, normal; 4, heterozygous sickle cell trait.(C) Ligation amplification was then

Fig. 21. LIgatlon Amplification as detection for polymerase chain reaction enriched
sequences. (A) BGP1 and BGP2, two 19-base-long oligonucleotide primers specific for p-globin gene,
were used with Taq polymerase to amplify a 294 bp fragment of p-globin gene. 2pg of genomic DNA was
used (b, p-thaiassemia; c, homozygous sickle cell; d, normal; e, heterozygous sickle cell trait) in 30 rounds
of PGR performed according to manufacturer's recommendation. Lane a is a control provided by the PGR
kit manufacturer. A 10 pi aliquot of PGR enriched genomic DNA from b-e was subjected to electrophoresis
in a 1.5% agarose gel at 60 V for 5 hr. (B) The PGR samples electrophoretically separated were
transferred to Genetran nylon membrane with 20X SSG overnight. The nylon membrane was hybridized
to 5'-[32p] labeled Hpi9S with 10 fold molar excess of unlabeled Hpi9A as competitor for 2 hr at 47 °G (a)
or hybridized to 5'-[32p] labeled Hp19A with 10 fold excess unlabeled H19pS as competitor (b). The
membrane was subsequently washed as described in Methods. 1, p-thalassemia sample; 2, homozygous

S2f

likewise positive for normal and sickle cell trait samples (Panel C lanes g and
h).

I.3.d

Allele Specific Poiymerase Chain Reaction.

Experimental Design. The scheme describing allele specific PGR
(ASPGR) is shown in Fig. 22. Primer P1 is designed such that it is
complementary to allele 1 but the 3' terminal nucleotide forms a single base-

pair mismatch with the DNA sequence of allele 2(*). Under appropriate
annealing temperature and PGR conditions, there would be normal

amplification of the P1-P3 fragment with DNA template containing allele 1
(homozygous or heterozygous) while little or no amplification from DNA

template containing allele 2 would take place. In a similar way, a primer (P2)
could be designed which would allow the specific PGR amplification of aliele 2
but not allele 1 DNA.

We designed two 14-nucleotide-iong aliele specific primers, Hpi4S and

H(314A, complementary to the 5' end of the sickle cell and normal p-globin
gene, respectively. The oligonucleotide primers differ from each other by a
single nucleotide at the 3' end. H314S has a 3' T and Hp14A has a 3* A. The 3*
nucleotide corresponds to the base-pair affected by the sickle cell mutation.

The oligonucleotide primer BGP2 [27], complementary to the opposite strand 3'
of the allele specific primers, was used as the second primer for PGR. The
amplification product with these primer pairs was 203 bp. Also included in each
reaction was a second pair of primers(GHPGR1 and GHPGR2) which directed

the amplification of a 422 bp fragment of the human growth hormone gene.

Fig. 22: Schematic representation of the ASPCR. P1 and P3,

synthetic oligonucleotide primers that anneal to opposing strands of a single
copy gene. P1 anneals to the region of a gene including the DNA sequence
variation such that its terminal 3' nucleotide base-pairs with the polymorphic

nucleotide of the template. P1 is completely complementary to allele 1 (A) but
forms a single base-pair mismatch with allele 2 ar the 3'-terminal position due to
one or more nucleotide differences relative to allele 1 (B).

gs

These primers were Included to provide an internal positive control.

Discrimination between normai and sickie cell aiieles.

Genomic DNA was isolate from peripheral blood leukocytes of individuals of
known p-globin genotypes (pA/pA^ pA/pS, pS/pS). in addition, DNA was isolated

from an EBV-transformed cell line containing a homozygous deletion of the p-

globin gene (pTh/pThj DNA was subjected to 25 rounds of PGR using either the
sickle cell sequence specific primer set(Hp14S and BGP2) or the normal pglobin sequence specific primer set (Hp14A and BGP2) using an annealing
temperature of 55 °C. The results are shown in Fig 23 A. It can be seen that a

203 bp fragment was observed using the sickle cell specific primer set only with

pA/pS and pS/pS genomic DNA templates. Conversely, the normal gene
specific primer set only gave rise to an amplification product with pA/pA and

pA/pS genomic DNA templates. As expected, the thalassemia DNA did not give
rise to a p-globin gene amplification product with either primer set. The internal

growth hormone gene control gave rise to a 422 bp fragment in all samples,
demonstrating that in no case was the absence of a globin specific band due to
a faiiure of the PGR.

In a single blind study, the DNA from 12 individuals with different p-globin
genotypes was analyzed with the two primer sets. The results are shown in Fig.

23 B. Individuais 1, 2, 3, and 5 are predicted to be pA/pA, individuals 6, 9,10,

and 11 are predicted to be pS/pS and individuais 4, 7, 8, and 12 are predicted to

be pA/pS. In each case the genotype was correctly and unambiguously
predicted from the pattern of fragment amplification (see legend to Fig. 23 for
clinically diagnosed genotype).

Fig. 23 The use of ASPCR for diagnosis of sickie ceii. (A)

Identification of the normal (P^) and the sickle cell (pS) alleles by ASPCR.
Normal (P^/pA), homozygous sickle cell (pS/pS), heterozygous sickle cell
(pA/pS), and homozygous thalassemia (P^h/pTh) dna samples (0.5 pg each)
served as template using either the normal (a primer set) or the sickle cell (s
primer set) containing an additional primer set for the human growth hormone
gene (hGH primer set) that directed the amplification of a 422 base-pair
fragment of the human growth hormone gene. After amplification, 15 pi from
each reaction mixture was subjected to electrophoresis in a 1.5 % agarose gel
for 2 hr at 120 V. Ethidium bromide staining of the agarose gel was used to
detect PGR amplified fragment. Positive p-globin ASPCR can be identified by
the presence of a 203 base-pair fragment using either the a or the s primer set

reaction. As a marker for the globin-specific fragment, 0.3 pg of the pHpA
containing the normal human globin gene (pA) was amplified with the a primer
set alone (Ml). As a marker for the growth hormone-specific fragment, 0.1 pg of
plasmid pXGH5 containing a 3.8 Kilobase fragment of the human growth
hormone gene (hGH) was amplified with the growth hormone primer set alone
(M2). (B) A single blind trial using ASPCR to diagnose the p-globin genotype

of genomic DNA samples. Genomic DNA samples from 12 individuals (4 each
of normal, homozygous, and heterozygous sickle cell individuals) were
randomly assigned numbers 1-12 by the hematology laboratory and blinded to
the investigators. ASPCR was performed using the normal (a) and the sickle
cell (s) primer sets as described above. Genotypes were identified as
homozygous normal (pA/pA) if the single 203 base-pair fragment appeared

exclusively in the a primer set reaction, as homozygous sickle cell (P^/p^) if the
203 base-pair fragment appeared only in the s primer set directed reaction, or

as heterozygous sickle cell trait (pA/pS) if the fragment appeared in both
reaction sets. The genotype of these DNA samples were previously determined
by hemoglobin electrophoresis (results not shown). The genotype of the 12

individuals were as follows: 1, 2, 3, and 5 , pA/pA; 6, 9, 10, and 11, pA/pS; 4, 7, 8,
and 12, pS/pS.

individual

primerset

individuai

primerset

individuai

primerset

1

2

3

4

sa sa sa sa

5

6

7

8

sa sa sa sa

9

10

11

12

sasasasa

1.4.

l.4.a.

DISCUSSION

Direct Analysis of single nucieotide variation in human DNA

and RNA using In situ Dot Hybridization

In the present work, we have demonstrated that short, synthetic
oligodeoxyrlbonucleotide probes can be utilized to directly identify the presence

of a specific DNA sequence within the genome without prior electrophoretic
separation of the DNA.

Agarose gels were chosen for dot immobilization for several reasons.

Much higher hybridization signals were obtained using oligonucleotide probes
with dried gels than with membrane filters [72, 88]. Furthermore, dried agarose
gels are suitable for multiple rounds of hybridization, and there appears to be a

lower overall background obtained with DNA immobilized in gels than with DNA

immobilized on a membrane (compare to Rabin and Dattagupta, 1987 [89]).
Finally, the gels have a much higher capacity for DNA than membranes.
As with electrophoresed DNA samples, in sUu dot hybridization allows
the detection of specific genes as well as discrimination between two genomic
DNA samples containing genes which differ by a single base pair in the region
of the oligonucleotide probe. As we have suggested, current methods for the
detection of DNA sequence variants in the human genome are labor intensive,

thus making large-scale genetic population studies or disease carrier screening
impractical. The application of oligonucleotide hybridization to genomic DNA

immobilized in dots simplifies existing oligonucleotide techniques for the
detection of DNA sequence variation without sacrificing the specificity of the
probe binding.

The approximately 10^ DNA sequence variants thought to exist in the

human genome [3, 4] are responsible for the considerable amount of genetic
variation between individuals. Polymorphisms which are located sufficiently
close to a gene responsible for a disease can serve as a practical genetic
marker to follow the inheritance of the linked trait [90, 91]. To date, restriction
fragment length polymorphisms have been the major type of marker used for

this purpose. Polymorphisms defined by oligonucleotide probes

(oligonucleotide hybridization polymorphism or OHPs) represent a potentially
new type of genetic marker. A disadvantage of this latter approach is the

difficulty is discovering useful polymorphisms. The major advantage, however,
is that the entire pool of genetic variation in the human genome is amenable to

analysis using allele specific oligonucleotide probes. Msilu dot hybridization,
therefore, represents a new tool to facilitate genetic disease diagnosis, HLA

typing, and polymorphic locus identification. Furthermore, the same technique
can be applied equally to DNA and RNA, making it possible to analyze the
expression of polymorphic sequences.

The difference between the |3-globin gene of normal (pA/jjA) and sickle

cell disease pS/pS) subjects is merely a single A->T transversion mutation in
codon 6. The ability of the synthetic oligonucleotide probes, Hp23S' and
Hp23A', to discriminate between the two DNA samples was demonstrated in
this report (Fig. 2 and 3). When the unlabeled mismatched probe was included

as hybridization competitor at a 10 fold higher concentration, the perfectly
matched hybridization signal was not diminished while the single base-pair
mismatched hybridization was completely suppressed. This study then

established a simple method to diagnose sickle cell disease and determine pglobin genotypes. Moreover, oligonucleotide probes could be applied to

identify any single base-pair change of a unique sequence in the human
genome.

The 23-nucieotide-long HLA-B27 probe remained selectively hybridized
to DNA from HLA-B27 donor source after extensive washing under stringent
conditions. We have shown that HLA-B27 probe exhibited single copy gene

hybridization by binding stably to a single DNA fragment from the genomic DNA
digest immobilized in both electrophoresed and in silu dot gels (Fig. 3). In this
manner, HLA-B27 probe was used successfully to identify individuals having
this HLA antigenic type. Because this antigenic type was found to have a
significant correlation with the disease ankylosing spondilitis and other

spondyloarthropathies [92, 93], HLA-B27 probe can be used as a screening tool
for high risk patients (i.e., patients with inflammatory bowel disease, psoriasis,
or Reiter's Syndrome). Moreover, the application of HLA-B27 probe establishes

the possibility that HLA matching can be done at the DNA level. For organ
transplantation procedures, for instance, one can imagine devising a series of
probes to genes coding for various antigens of interest. The best matched

donor could be identified merely by comparing the hybridization patterns of
various probes to genomic DNA of the patient and potential donors. This

technique would offer the advantage of greater accuracy over the current
serologic techniques. However, this procedure presently requires
approximately three days to complete, which would make it more time
consuming than current methods.

I.4.b

Ligation Amplification Reaction 1: Specificity of the nick-

closing activity of bacteriophage T4 DNA ligase

Bacteriophage T4 DNA ligase catalyzes the joining of DNA fragments
with cohesive and blunt ends, as well as sealing nicks in double stranded DNA
molecules. Our results demonstrated that ligase can also effectively join short,

synthetic oligodeoxyribonucleotides on complementary DNA templates. This
reaction was highly specific (Fig. 6). A single mismatch between the substrate

oligonucleotide and the template at the ligation junction reduced the efficiency
of the phosphodiester bond formation. It is clear from the accumulation of the 5'
adenylates (Fig. 10) that both oligonucleotide substrates bound at least
transiently to the template with their ligation ends at the enzyme catalytic site.
Despite this, only a fraction of the template-mismatched oligonucleotide pairs
were ligated to form the stably bound 22-nucleotide-long product. The reduced

ligation efficiency reflects, at least in part, the specificity of the ligase catalytic
site, although the mismatch undoubtedly influenced the stability of the
oligonucleotide-template duplex.

The enzyme specificity can be expressed in terms of the amount of match

ligation relative to mismatch ligation under an established condition (see Fig. 11
and Table 6). The specificity ratio was four to five times greater for the

0N1/0NA2 pair than for the ONA3/ON4 pair in the absence of NaCI (Table 6).
This finding was likely due to the fact that the mismatch present in the octamer
substrate was more destabilizing than one occuring in a tetradecamer

substrate. A single base-pair mismatch clearly destabilized the annealing of
the octamer substrate to a much greater extent than the tetradecamer substrate.
However, the possibility also exists that the enzyme has a more stringent

requirement for the 3' substrate than for the 5' substrate. For example, T4 DNA

ligase is capable of joining 5' phosphoryl poly(dA) to 3', 5' hydroxy poly(A) on
poly(dT) template: on the other hand, the same enzyme is incapable of joining

5' phosphoryl poly(A) to 3', 5' hydroxy poly(dA) on the poly(dT) template [94],
This differences in the 3' and 5' substrate requirements clearly reflect intrinsic
and salient enzymatic features.

The effect of temperature on the ligation reaction was biphasic with
optima at 28 °C and 37 °C (Fig. 8). Since T4 DNA ligase functions optimally at
37 °C [36], the biphasic nature may reflect the influence of oligonucleotidetemplate annealing on the overall oligonucleotide ligation efficiency.
NaCI at 200 mM is inhibitory to T4 DNA ligase, altering both the Vmax

and the apparent Km of the enzyme for the template (Fig. 9). Our finding
confirms the report of Raae et al. [47], who observed a large increase in the

apparent Km of the enzyme for the DNA substrates with the addition of NaCI. In
our system, the apparent Km was increased approximately 4 fold from 0.05 pM

to 0.2 pM. It should be noted that the very high Km for template means that
detection of ligation at low template concentration has unfavorable kinetics.
The kinetic patterns (Fig 9) showed that NaCI acts as an noncompetitive

inhibitor interacting quite possibly with the enzyme or the enzyme-substrate
complex. The positively charged sodium ion may disrupt various chargecharge forces needed for stabilizing the enzyme-substrate interactions and/or

for properly positioning of the substrate ends at the catalytic site, in these

cases, the affinity of the enzyme for the substrates and catalytic efficiency would
then be reduced.

It has been clearly established that both monovalent cations and
polyamines stabilize bihelical DNA structure [44, 48]. This effect is in direct

contrast to raising the reaction temperature which destabilizes the DNA duplex.
Yet, both higher salt concentration and increased temperature enhanced the

specificity ratio by reducing mismatch ligation. It is likely that suppression of
mismatch ligation by NaCI is mediated through its alteration of the catalytic site.
On the other hand, raising reaction temperature thermally disrupts the more
unstable mismatched DNA duplex. Our results also indicated that the

accumulation of the 5' adenylate with mismatched substrate closely followed
the formation of the mismatch products (Fig. 12). This suggests that the

adenylate accumulation drives the mismatch ligation reaction. Both salt and
spermidine inhibited the formation of 5' adenylate and, not surprisingly, the
formation of mismatch ligation product as well.

T4 DNA ligase has been shown to ligate two adjacent nucleotide
sequences on an appropriate template even if the nick contains a mismatched

base-pair [95, 96] or an apurinic site [96]. Even single nucleotide gaps can be
joined by the enzyme [43, 96]. In this thesis, we have demonstrated that the

fidelity of the joining of adjacent oligonucleotide pairs is greatly improved at
higher salt or spermidine concentrations. Under optimal conditions, 14 DNA
ligase is capable of distinguishing substrates that are perfectly matched at the
ligation site from those that contain a mismatched base-pair. Escherichia coli
DNA ligase appears to be equally specific in our preliminary studies. It is
possible that this feature is characteristic in all ligases. This possibility would
suggest a participatory role for DNA ligase in the maintenance of an organism's
sequence integrity. Given the many nicks generated in DNA replication and by
DNA repair enzymes, ligase must be able to selectively rejoin only those

junctions that are correctly paired. High cation and polyamine concentrations in
the cell further enhance the ability of DNA ligase to discriminate mismatches.

Recently Landegren et al. (1988) reported the use of T4 DNA llgase in a
method for the detection of point mutations [97]. Their technique involves the

ligation of two 20-nucleotide-long oligonucleotides on a DNA template. One of

the oligonucleotides contains the label (radioactivity or fluorescence) while the
other contains biotin. The ligation product could then be detected by the
binding of the label to an avidin-containing support. As in the case of our study,
Landegren et al. showed that a single base pair mismatch at the ligation
junction reduced the amount of ligation product considerably. A similar
observation has recently been made by Alves and Carr [98].

1.4.0

Ligation Ampiification Reaction II:

Amplification of specific

DNA sequences using sequential rounds of template-dependent
ligation.

The highly specific nature of the T4 DNA ligase nick closing reaction
enables us to present here a simple and novel DNA sequence detection
methodology based on the ligation of flanking oligonucleotide pairs on DNA
templates and the amplification of ligated products by sequential rounds of

ligation (Fig. 14). This methodology, which we term the ligation amplification
reaction or LAR, can be applied to detect single base-pair differences in DNA
samples. In the first step of ligation amplification, the oligonucleotide substrates

were allowed to anneal to the template sequence such that the last base of one
of the oligonucleotide strands base-paired to the target base of interest. When
complementary base-pairing existed at the ligation junction, bacteriophage T4

DNA ligase joined the substrate pair forming a longer product that was stably
bound to the template. A mismatch at the pair junction, however, prevented

ligation between the two oligonucleotide. This salient feature determineed the

specificity of the detection reaction. Once the ligated products formed,

subsequent amplification steps multiplied the products exponentially. Existing
ligation products served as templates for the subsequent ligation of more
substrate pairs. If the initial ligation step did not take place as a result of base-

pair mismatch, amplification steps did not give rise to detectable ligation signal.
In this manner, the identification of a single base-pair could be made on small
amounts of genomic templates.

It is quite clear from the amplification scheme that the initial rounds were

especially important in two ways. First, in initial rounds the original DNA sample
was the primary template for ligation; therefore the intrinsic specificity of the
system depended on the ligase specificity in these rounds. In later rounds, the
predominant templates were the ligation products which did not contribute to

single base pair discrimination. Second, any undesirable template
independent ligation would contribute significantly to the final signal because
these products could serve equally well as templates for amplification.

The major template-independent reaction in the ligation amplification
system is joining of blunt end duplexes {0N1:0N4 and ON2:ON3), to each other
and to themselves. Four possible 22-base-long products result from blunt end

ligation, all of which can serve as templates for further amplification. It is

imperative to inhibit the formation of these blunt end ligation products especially
in the initial rounds. Both NaCI and Pi were effective in suppressing blunt end
ligation even in the presence of 5% PEG, which promotes blunt end ligation
(Fig. 17). We choose to include 200 mM NaCI instead of Pi in the reaction

mixture because of the additional enhancing effect of NaCI on ligase specificity.
NaCI at 200 mM, for example, suppressed mismatch ligation and enhanced the

specificity ratio of T4 DNA ligase by 10-25 fold (see results section l.3.b.).
Moreover, Pi is a more potent inhibitor of the enzyme activity than NaCI
(unpublished observation).

Both hexamer and octamer oligonucleotides were tested as the 3'
substrate for LAR. While both were equally effective as oligonucleotide
substrates in first-strand template-dependent ligation, amplification of the
product occurred only with the octamer 3' substrate system at 30 °C (Fig. 16).

Slow second-strand ligation, however, did take place for the 6-nucleotide-long
substrate system at 15 °C, thereby, indicating that the 20-nucleotide-long
ligation product from this system is an inefficient template for further ligation of
substrate pairs. The most likely explanation for this phenomenon is the
instability of the transient duplex formed by the subsequent annealing of the
tetradecamer substrate to the 20-nucleotide-long product. This duplex is
stabilized by the base-pairing of 6 complementary nucleotide region and this
region is flanked by long unpaired single nucleotide strand on either side. At 30

°C, the thermal motion of the unpaired regions is likely to destabilize the
existing base-paired region. When the reaction temperature was reduced to 15

®C, the complex becomes more stable, hence allowing the annealing of the 6
base long 3' substrate and the subsequent joining of the two oligonucleotides
on the 20-nucleotide-long template.

At high template concentration (above 1 nM), the efficiency of the ligation
amplification was essentially 100 %(Fig. 18). In each round, ligation products
doubled in amount. However at low template concentration, the ligation
reaction in each amplification round appeared to be considerably slower. This
observation was expected given the apparent Km of the enzyme for
oligonucleotide template as 1-5 pM in the presence of 200 mM NaCI. At

template concentrations of 1 x 10®-fold below the apparent Km, T4 llgase
activity slows down considerably. This kinetic constraint forced us to resort to

longer incubation time and greater number of rounds. Some 60-70 rounds
were required to identify the LAR product under the conditions of the experiment

described in Fig. 20 using 5 pg of genomic DNA. The entire length of the
amplification reaction is approximately 90-100 hr. Obviously, the use of

oligonucleotides of higher specific activity would have reduced the number of
rounds.

As currently performed, LAR would appear to be a rather impractical
method for the diagnosis of single nucleotide variations in genomic DNA. This
is because of the long incubation times required as well as because of the need

to add fresh enzymes at the beginning of each round. The latter problem was
also a limitation of the PGR reaction when it was first introduced [14] and
suggests that the use of thermal-stable llgase for LAR might improve its utility
[99]. The advantage of such an enzyme would be that the reactions could be
performed in a thermal cycler without requiring frequent additions of fresh

enzyme and, therefore, the process could be automated. Furthermore, higher
initial enzyme concentrations and higher reaction temperatures might also
produce more favorable rates of reaction. An additional potential advantage of
a thermal-stable llgase is that this enzyme, or any other DNA llgase for the

matter, might have a lower Km for template than the T4 DNA ligase. This would
reduce the reaction time required for LAR.
If higher temperature were used with a thermostable ligase, it would

probably be necessary to use longer oligonucleotides in the reaction. Whether
longer oligonucleotides would provide a similar degree of mismatch
discrimination as seen in this study is not known. Landegren et al. [97] have

shown highly specific ligation of adjacent 20-nucleotide-long oligonucleotide

pairs on appropriate templates.

When the 3' nucleotide of the 5'

oligonucleotide formed a single nucleotide mismatch with the template, ligation
was inhibited. On the basis of these observations, specific ligation amplification
should be specific with longer oligonucleotides.

To overcome the present kinetic constraint of LAR, the number of

genomic template copies was enriched using PGR [14]. Ligation amplification
applied to the PGR- enriched templates gave clear identification of the genotype
of four different DNA samples in four rounds (Fig. 21)

In this study we have examined the effects of only two (T-T and A-A) of
the eight possible mismatches(A-A, T-T, A-G, G-G, G-G, G-T, G-T, and A-G). It is
not clear whether the six additional mismatches would be equally effective in

inhibiting ligation amplification. Landegren et al. [97] have also shown that all
eight mismatches do inhibit ligation of adjacent oligonucleotide pairs. Because
the amplification of LAR is exponential and is dependent upon the efficiency of
each round of amplification [14], very minor effects on the efficiency of each
round of amplification will have rather profound effects on the overall yield of
product after many rounds. Therefore, it is reasonable to assume, based on the
results reported by Landegren et al., LAR will be specific for all eight
mismatches.

In the present thesis, we demonstrated the use of oligonucleotides and
T4 DNA ligase in a single base-pair detection system. The concept of ligation
amplification offers clear advantages over existing methods in its simplicity and
its precision. LAR can be applied to identify any DNA template for which the
sequence is known. With further improvement, LAR may become a valuable
molecular diagnostic tool for the detection of specific target sequences for

genetic diseases, genotypic analysis, pathogen detection, etc.

I.4.d.

Allele Specific Poiymerase Chain Reaction.

The results presented in the previous section (Results, section IV)
indicate the potential usefulness of ASPGR for sickle cell diagnosis. This
method is rapid and does not use radioactivity, since all that is required is to
visualize the band on a gel with ethidium bromide staining. It should be
possible to improve the technique by further by eliminating the gel separation

step. One strategy for this is shown in Fig. 24. As proposed recently by Yamane
et al.[100], the two primers for the PGR reaction could be labeled differently,
one with biotin and one with a fluorescent group such as fluorescein or
tetramethyl rhodamine. The product of the PGR could be captured in

streptavidin-agarose and the presence of the amplified sequence could be
detected by fluorescence. In this case, if one allele-specific primer were labeled

with one fluorescent group and the other with a different one, then the ASPCR
could be done simultaneously.

In this study we have used PGR primers that form either an A-A or a T-T
mismatch. It is not clear that other mismatches will give equally effective
discrimination. Since G-T mismatches are more stable than other mismatches

[101], G-T mismatches should probable be avoided when designning primers
for ASPCR. This can be done by designing the primer so that is is
complementary to the strand with which it forms an A-C mismatch. It may be
possible to use a competition approach, as we have previously used to improve

discrimination provided by oligonucleotide hybridization probes [19]. In this

PCR
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case, a competitive primer could be designed that isnot able to prime, for

example, by including in it a 3' dideoxynucleotide or a 3' ribonucleotide that has
been oxidized. A mixture of a labeled allele-specific primer complementary to

allele 1 plus an unlabled priming-defective primer complementary to allele 2
should then allow the specific amplification of allele 1.
The ability of an oligonucleotide to prime on a DNA template is governed
by two kinetic variables: the rate constant of primer dissociation from the
template before initiating polymerization (koff) and the rate constant of the DNA

polymerase extension of the primer (kpoi). The mathematical equation
governing polymerase chain reaction priming efficiency isahown below (see

Notes No. 1 for the mathematical derivation)

d/dt[P*DNA]= rate of successful priming = kon kpo|/koff + kpoi[dNTP][P][DNA]

This equation predicts that efficient priming in PGR would take place whenever

kpoi»koff and the rate of successful priming would be equal to kon [dNTP][P]
[DNA]. In this case, the addition of the first few nucleotides then greatly
stabilizes the oligonucleotide-template complex and thereby allows continued

extension of the primer. However, when koff»kpoi effective priming would not
take place because primers would dissociate from the template before the

catalytic extension of the primer could take place. The rate of successful

priming is then very low. For a given primer kpoi is an intrinsic property of the
polymerase. Studies with £. £Q]i DNA I have suggested that this polymerase
may be able to discriminate between primers that either do or do not form a

mismatch with the template at the 3'-terminal nucleotide [102]. In this case kpoi

for the mismatched primer was smaller than kpoi for the perfectly matched

primer. For the present study, we designed the allele-specific primers such that
the allele-specific nucleotide in the template was complementary to the 3'
terminal nucleotide of the primer (Fig. 22). In this way, the 3' nucleotide of the

primer specific for one allele would form a mismatch with the template of the
other allele. This design allows one to take advantage of the difference

between the kpoi of the perfectly matched and mismatched primers, as well as
to optimize primer concentration, priming temperature, primer length, and
primer sequence, all of which affect the difference in the koff for the two allelespecific primers.

We reasoned that a set of conditions should exist such that kpoi>koff for
the perfectly matched set of primers, while kpoi<koff for the mismatched primer.
The results shown here clearly demonstrate this to be true. In our study allele
specific primers were 14 nucleotides long. We found that discrimination

between |3^ and

alleles was not possible at low annealing temperatures

(e.g., 44 ®C and 50 °C: data not shown). Presumably the short length of the
oligonucleotides, as well as the high annealing temperature, combined to
provide the discrimination.

I. aquaticus DNA polymerase is well suited for the use in ASPCR for the
discrimination of two alleles that differ by a single nucleotide because it lacks a
3'->5' exonuclease activity [103].

If such an activity existed on the Tag

polymerase, it would correct the mismatched base at the primer terminus and

then proceed with the synthesis using the one-nucleotide-shorter primer. Since
the specificity of the ASPCR is determined by the initial cycles of PGR, the fact
that the primer remains uncorrected enhances the discrimination of the reaction.

PGR is an exponential reaction; the yield of product is very dependent on the
efficiency of each round [14]. Very minor changes in the efficiency of each

round of amplification have profound effects on the overall yield after many
rounds. For example, if the efficiency of the reactionwere 90% with the perfectly
matched primer and 60% with the mismatched primer, there would be 73-fold
more product in the first case than the second at the end of the last round.

As with LAR, ASPCR should find application in the field of genetic
diagnosis, carrier screening, HLA typing, and other nucleic acid-based tests in

which the precise DNA sequence of the priming site is diagnostic of the target.
In the case of HLA typing, recent advances have used PGR amplification
followed by allele specific oligonucleotide hybridization for the for the

determination of DR, DQ, DP alleles [11, 104-106]. It should be possible to use
ASPCR for the direct analysis of HLA types.

11.1.

INTRODUCTION

For over twenty years, studies in gene regulation have suggested that
gene expression is governed mainly by activator or repressor proteins that

interact with regulatory elements in the vicinity of the gene. Recently, naturally
occurring RNA repressers have been found which inhibit the expression of
endogenous bacterial and eukaryotic genes along with genes deriving from
virus, episomes, and mobile genetic elements [49, 50]. These regulatory RNAs
appear to act by annealing to mRNA of the target gene at complementary
sequences thereby arresting either the splicing or the translation processes.

These RNAs are referred to as "antisense RNAs" to designate their action and

their direction (i.e., they are complementary and antiparallel to the mRNA).
The discovery of these naturally occurring antisense RNA molecule was

novel at the time but should not have been unexpected. Approximately 10
years ago, Stephenson and Zamecnik raised the intriguing possibility that a

short synthetic oligonucleotide whose sequence is complementary to a given
gene could be used to inhibit the expression of that particular gene in vivo [51,
52]. Their pioneering work demonstrated that tridecamer

oligodeoxyribonucleotides synthesized complementary of the reiterated

terminal sequence of the Rous sarcoma virus(RSV) inhibited the production of

RSV and the transformation of chick embryo fibroblast tissue cultures infected
with RSV. Since then, the numerous reports of the antisense activity of
synthetic oligonucleotides and oligodeoxyribonucleoside methylphosphonates
certainly suggest that sequence specific inhibition of gene expression can be
used as a viable tool for genetic studies [53, 54]. These reports also raise the

interesting possibility of using short synthetic oligonucleotides as antiviral or
antineoplastic therapeutic agents [55, 56].
An antisense oligonucleotide, when added directly to the nutrient
medium, must first cross the cell membrane to reach the cytoplasm, where it
may interfere with the message translation process. If the oligonucleotide
sequence is designed to interfere with nuclear processing, the oligonucleotide

then must penetrate the nuclear membrane as well. Upon reaching the
subcellular target, the antisense oligonucleotide is presumed to anneal to the
target sequence of the mRNA, hnRNA, viral, or cellular genome. Through the

Watson-Crick base-pairing, the antisense oligonucleotide forms a duplex with

the target RNA or DNA. The annealing of the oligonucleotide is then postulated
to impair a number of cellular processes, namely translation of the message by
ribosomes, transport of RNA, replication of the viral genome in retroviral infected
systems, or splicing the messages. Although, like the antisense RNA, antisense

oligonucleotides have been demonstrated to form duplex molecules with mRNA
in vitro [57, 58], whether the antisense oligonucleotides exert their action

through a sequence specific mechanism in vivo remains controversial [59, 60].
It is quite possible that less sequence specific mechanisms also operate in vivo
causing inhibition of gene expression that is not easily be destinguished from
the results of the sequence specific mechanism. For example, RNase H, the
enzyme that cleaves the RNA portion of a RNA-DNA hybrid duplex is known to

exist in many cell lines [59, 60, 61]. RNase H has been shown to enhance the
inhibitory effect of antisense oliaonucieotides in vivo and in vitro f59. 62, 63]. In
this scenario, antisense oligonucleotides could be inducing RNase H activity,
thereby causing a rapid and preferential degradation of the target RNA. The
precise target of the antisense sequence, therefore, would be much less
important. Any sequence complementary to the mRNA would arguably be
sufficient.

A review of published reports in this field shows considerable variability
in terms of the levels of inhibition produced by antisense oligonucleotides and
in terms of the concentration necessary to produce the inhibitory effects [60]. In
general, antisense oligonucleotides designed against viral targets produce the
most consistent inhibition, ranging from 56% to 100% [53, 60, 64, 65]. The

effects of antisense oligonucleotides directed against cellular genes are much
less consistent, ranging from 33% to 100% [56, 57, 66, 67]. Many other reports
merely describe the antisense activity in terms of phenotypic changes. Most of
these studies lack adequate controls for cellular growth and conditions, without
which the alleged antisense inhibition could be confounded by effects of
oligonucleotide cytotoxicity. In many of these studies, measurements also

require that the treated cells be broken open and assayed for an intracellular
component, a membrane antigen, or viral production. The physiological
condition of the treated cells is therefore extremely important. Reduced cell

numbers caused by either cytotoxic or cytostatic effects, for example, may be
misinterpreted as an inhibitory effect.

In the present thesis work, we have designed a well defined eukaryotic
system in which the final assay does not require cell disruption. We transfected
mouse thymidine kinase negative L cells with plasmid DMA containing a human

growth hormone (hGH)gene immediately downstream from either the mouse
metallotheinin promoter or the thymidine kinase promoter. Stable
transformants were then isolated. These murine cells produced hGH and the

hormone was released into the tissue culture medium [68]. Little or no hGH was
retained in the L cells. hGH in the medium was then easily assayed with

commercially available radioimmunoassay systems. The viability of intact cells
was also determined before disrupting the cells for isolation of total RNA.

The hGH gene is 2.2 Kbp in length and contains five exons and four
introns [69, 70]. When transfected into mouse cells, the DMA is incorporated
into the mouse genome. The upstream promoter drives the transcription of the
hGH gene and hGH RNA is processed into hGH mRNA. The system thus

represents a true eukaryotic model for testing antisense oligonucleotides.
We constructed oligomethylphosponates (each 8 nucleotides long) and
the oligodeoxyribonucleotides (each 15 nucleotides long) in both the sense
and the antisense orientations. These antisense oligonucleotides (dNP) and

oligomethylphosphonates(CMP) were designed to inhibit various steps of the
processing of the hGH gene transcript to mRNA or the translation of the mRNA
to hGH. The test targets of the antisense oligonucleotide includes the donor

splice site and the acceptor splice site of the second intron of the hGH transcript,
the translation start site at the region of the first codon, and a stretch of
polypurine in the third intron of the hGH gene.

We tested the hypotheses that: 1) antisense oligonucleotides function in
a sequence specific manner, 2) antisense oligonucleotides can be designed to
specifically inhibit transcription by forming the predicted triple helix with

polypurine-polypyrimidine regions of the gene, and 3) two adjacent antisense

oligonucleotides produce inhibitory effects equivalent to a single

oligonucleotide of their combined length.

.2.

MATERIAL AND METHODS:

Tissue culture. Thymidine kinase negative L cells (LTK") were grown

In Dulbecco modified eagle low-glucose medium (DMEM)containing 10% fetal
calf serum (PCS), 10 mM Hepes buffer, 2 mM L-glutamine, and 20 pg/ml

Gentamycin sulfate. Cells transformed with the thymidine kinase (TK) gene
and human growth hormone (hGH) gene were propagated in DMEM
supplemented with 10 % PCS, 10 mM Hepes buffer, 2 mM L-glutamine, 20
|ig/ml Gentamycin sulfate, and HAT(HAT = 100 pM hypoxanthine, 0.4 pM

aminopterine and 16 pM thymidine.) All cell cultures were maintained at 37 °C
in V. I. P. Imperial II CO2 incubators under 5% CO2. Media and solutions used
in tissue culture procedures were sterilized by filtration through a Nalgene
disposable filtration unit (0.2 pm pore size).
Cells grown in culture were followed with light microscopy and the

cultures were split into 1/4 of the original cell density whenever the growth

approached confluence in tissue culture flasks (Palcon). Cell splitting

procedures were performed by rinsing the cell layer with versene (137 mM
NaCI, 2.7 mM KCI, 8 mM Na2HP04, 1.5 mM KH2PO4. 0.5 mM EDTA and

0.005% phenol red) for 1 min and treatment with 0.0025% trypsin in versene for
5 min. An equal volume of DMEM containing 10% PCS was added to the
trypsin treated cells to inhibit further tryptic digestion. The mixture was then

centrifuged at 4000 rpm in Beckman Model TJ-6 Centrifuge for 10 min. The
supernatant was removed and the cell pellet was resuspended in 1 to 5 ml of
the appropriate medium before the viable cell density was determined in Trypan
blue dye with a hemacytometer. The cells were diluted and replated
appropriately.

Plasmid isolation procedures. Plasmids pOGH, pTKGH, and
pXGH5 were kind and generous gifts from Dr. Richard Selden, Harvard

University. pOGH contains a 2.1 Kbp of human growth hormone (hGH) insert in
pUC12 plasmid vector flanked by a Bam HI and an Eco R1 restriction sites [68].

The same 2.1 Kbp hGH insert was cloned into pUC12 vectors in the pTKGH and
pXGHS plasmids with the addition of either a 0.3 Kbp thymidine kinase (TK)
promoter or a 1.8 Kbp mouse metallothionein I (mMT-l) promoter upstream,
respectively.

MC1061 E-

host cells were selected to grow the plasmids. The host

cells were plated on a YT (yeast-tryptone) agar plate and grown overnight at 37

°C. A single colony was taken from the plate and inoculated into ICQ ml of LB

broth (10 g of Bacto-tryptone, 5 g of Bacto-yeast extract, and 10 g of NaCI per
liter[pH 7.5]. The cells were grown with vigorous shaking at 37 °C for 2 to 4 hr
until the cells were growing in mid-log phase (absorbance at 600 nm = 1.0).
The cell suspension was quickly chilled on ice for 10 min and centrifuged at

8000 rpm for 10 min at 4 °C in the Beckman TJ-6 Centrifuge. To render them
competent for transformation the cell pellet was resuspended in 10 ml of 0.1 M
CaGl2 and left on ice for 30 min. The cells were again centrifuged at 8000 rpm

for 5 min and resuspended in 1 ml of 0.1 M CaCl2. Then 176 |xl of glycerol was
added to the cell suspension.

Aliquots of competent cells (50 pi) were frozen

quickly at -70 °C.

The frozen competent MC1061 cells were thawed and mixed with 1 pi of
plasmid (unknown concentration). The cells were heat shocked for 2 min at 42
°C and resuspended in 1 ml of warm LB broth. 100 pi of the cell suspension
was then mixed with 3.0 ml of a 0.7% agar containing LB broth, 0.25 mg/ml

ampicillin, isopropylthio-p-galactoside (IPTG) and 5-bromo-4-chloro-3-indolyl-p-

D-galactoside (X-Gal) kept at 55 °C and layered onto the surface of a 1.5% LB
agar plate supplemented with ampiclllln. IPTG is an inducer of p-galactosidase
activity in bacteria and is used in combination with X-Gal to detect /ac gene

activity in cloning procedures. The plate was incubated overnight at 37 °C.
The transformants were identified as blue colonies on the agar plate.
A single transformed colony was inoculated into a 1 liter of double

strength YT medium supplemented with 150 pg/ml ampicillin. The culture was
grown overnight at 37 °C in a 2 liter flask with vigorous shaking. The bacteria

were harvested the next day by centrifugation in a Sorvall RC-3B centrifuge at
4000 rpm for 15 min. The large scale plasmid preparation was performed

according to a modification of the method described by Birnboim and Doly [78].
In this procedure, cells were digested in a glucose solution (50 mM glucose, 10
mM EDTA, and 25 mM Tris-HCI[pH 8.0] with 2 mg/ml lysozyme for 5 min at room

temperature. The cells were lysed with NaOH-detergent (0.2 N NaOH and 1%
SDS). Neutralization with acetic acid, centrifugation, and RNAse treatment
removed the high molecular weight DMA and RNA, leaving small DMA
molecules in the supernatant. The mixture was extracted twice with phenol and
chloroform and the low molecular weight DMAs were precipitated by ethanol at -

70 °C. The final purification step involved an equilibrium ultracentrifugation in 1
g/ml cesium chloride with 0.1 mg/ml ethidium bromide for 45 hr at 38,000 rpm
and 17 °G. The lower florescent band from the cesium chloride gradient was

removed with a syringe and extracted three times with isobutanol. The isolated

plasmids were then characterized by Eco R1 digestion and spectrophotometry.
The average plasmid yield for this method was approximately 0.5 to 1 g.

Transfection and isolation of stable transformants. 5x 10^ LTK*
cells were plated on Corning 100 mm x 20 mm tissue culture grade petri dishes

and allowed to grow overnight at 37 °C under 5% CO2. These cells were co-

transfected with hGH plasmid and thymidine kinase plasmids using the CaCl2DNA transfection procedure [79]. CaCl2-DNA solution was prepared by mixing
20 ng of TK plasmid DNA containing thymidine kinase gene, 20 pg carrier DNA

(LTK* cell DNA), 0.25 M CaCl2 and 1 pg of DNA containing the appropriate
human growth hormone gene. One mililiter of this CaCl2-DNA solution was

added dropwise to 1 ml of Hepes-phosphate solution (42 mM Hepes [pH 7.1],
0.274 M NaCI, and 1.4 mM sodium phosphate) while the mixture was bubbled
with a constant stream of air. A whitish, flocculent precipitant was formed as the

result. Prior to the calcium phosphate-DNA transfection procedure, the medium
was withdrawn from the tissue culture plates and the cell monolayer was rinsed
with versene solution. The cells were then transfected with the 2 ml of the

calcium phosphate DNA precipitate along with 8 ml of fresh medium. The cells
were left overnight at 37 °C. The calcium phosphate DNA medium was
removed the next day and replaced with 10 ml of fresh DMEM supplemented
with HAT for the selection of the thymidine kinase gene expression. The cells
were allowed to remain in the selection medium for 10 to 12 days before a
single 100 pi aliquot of medium was withdrawn and assayed for the presence of
hGH. The selection medium was then replaced with fresh selection medium in
plates which were assayed for hGH production. The viable cells which also
produced hGH were followed under light microscopy until cells formed colonies.
To isolate stable clones, two strategies were applied: the cells were

either serially diluted until single cells could be pipetted into wells of a 96 well
tissue culture plate or directly isolated as a single colony using a cloning

cylinder. With the first strategy, cells were lifted from the 100 mm petri dish with
trypsin and counted in a hemacytometer. A series of dilutions with DMEM-HAT

media brought the concentration of the cells down to a range where each

aliquot pipetted into a well carried approximately 0.3 cell. As expected, only 1/3
of all wells contained a single cell which eventually formed a colony. If two or
more colonies were found in a well, it was discarded. The medium from each

well containing a single colony was assayed for hGH. With the second strategy,
the entire colony within a cloning cylinder was lifted with trypsin and transferred

into a single well of a 96 well plate. With either approach, once the colony was
isolated into a single well, the cells were grown first in the 96 well plate, then in
a 24 well plate, and finally in a 12 well plate. Those clones that tested positive

for hGH were transferred into 25 cm2 tissue culture flasks and finally
propagated in 75 cm2 flasks. The clones were carried for several splittings to
make sure they were stable in their expression of the hGH gene. The stable

clones were then stored frozen in 10% dimethylsulfoxide (DMSO) in liquid
nitrogen.

Human growth hormone assay. hGH levels in the media from

appropriate tissue cultures were measured with a solid-phase two site

radioimmunoassay kit under the conditions recommended by the manufacturer

(Hybritech or Nichols Institute). The measurable range of these assays was
between 0.1 ng/ml and 50 ng/ml. When samples contained greater than 50
ng/ml hGH, they were diluted with DMEM-HAT so that the hGH concentrations
were within the linear range.

Antisense experiments. "Direct inhibition of hGH expression in stable

transformants"- Antisense ollgonucleotides (either ollgomethylphosphonates
or oligodeoxyribonucleotides) were added to the DMEM-HAT medium at the

indicated concentrations. The stable cell lines expressing the hGH gene were
then grown in presence of the antisense ollgonucleotides for a defined period of
time before an aliquot of the growth medium was assayed for hGH production.

In typical experiments, 10"* cells were plated into each well of a 96 well plate
and allowed to settle for 6 hr. The medium from each well was removed and

replaced with 250 pi of DMEM-HAT medium containing ollgonucleotides. The
plate was then incubated for a specified time interval (usually overnight) at 37
°G before 100 pi was withdrawn from each well and assayed. Appropriate
negative and positives controls were always included to assess nonspecific and
cytostatic effects of the ollgonucleotides.

"Cotransfection of the LTK- cells with hGH gene and antisense

oligonucieotides" Gotransfections of LTK" cells with hGH gene and antisense
ollgonucleotides were carried out under conditions similar to the transfection

procedures for generating stable transformants (see above). However, the

transfections were performed on a smaller scale, often in 24 or 96 well plates.

Typically 10"^ cells were plated in each well and grown in 250 pi (for 96 well
plates) medium overnight at 37 °G. Galcium phosphate DMA solution

containing antisense oligonucleotide, but without the TK gene, was prepared
the next day as described previously. 50 pi of the calcium phosphate DMA
solution was then mixed with 200 pi DMEM (without HAT). After the overnight
medium was removed and the cells were rinsed once with versene, this mixture

was then pipetted into a single well. The cells were kept in the calcium

phosphate DNA solution for 24 hr before a 50 pi aliquot of the medium was
removed and assayed for hGH.

Determination of hGH mRNA and mRNA precursor ieveis with

PGR. Two PGR primers, GHPGR1 and GHPCR2, were designed to direct the
amplification of a 422 bp fragment of the human growth hormone gene across
intron 2. The fragment included sequences from both exons 2 and 3. The

spliced product of the hGH precursor RNA did not contain the 209 bp intron 2
and was, therefore, detected as a 213 bp fragment after amplification eith the
same set of primers.

Total cell RNA was isolated from the cells growing in each well of tissue
culture plates by the RNAsol method (Cinna/Biotecx)[80]. Cells in each well
were rinsed twice with versene and lysed with 200 pi of RNAsol. Wells were

checked under light microscopy to make sure cells were lysed completely. An
equal volume of chloroform was added to the RNAsol lysate. The sample was
shaken vigorously for 15 sec and allowed to remain on ice for 15 min. The

suspension was then centrifuged in an Eppendorf Centrifuge for 15 min at 4 °C.

The lower phase containing the phenol and chloroform was carefully removed
and the upper phase containing the RNA was re-extracted with another volume
of chloroform. Care was taken in the process not to disturb the material

between the two phases as it contains DNA and proteins. The extracted upper
phase was then transferred to another tube and precipitated with two volume of

ice cold ethanol at -20 °C for 1 hr. The sample was finally centrifuged for
another 15 min and the visible RNA pellet was washed twice with 75% ethanol.

Immediately upon dissolving the RNA pellet in water(20 pi), a 5 pi
sample was used for PCR analysis. 0.2 pM each of primers, GHPCR1 and

GHPCR2, along with 5 units of AMV reverse transcriptase were added to the
RNA sample to initiate the RNA dependent DNA synthesis for one cycle. The
reverse transcription was carried out in a volume of 50 pi containing 50 mM KCI,

10 mM Tris-HCI (pH 8.3), 1.5 mM MgCl2, 0.01% (w/v) gelatin, 0.5 mg/ml
template DNA, and 0.1 mM each of dATP. dCTP, dGTP, and TTP at 37 °C for 10

min. Subsequently, 2.5 units of Taq polymerase was added. Thirty cycles of
PGR were carried out. Each cycle consisted of 2 min of annealing at 55 °G, 3
min of polymerization at 72 °G, and 1 min of heat denaturation at 94 °G.

The PGR products (15 pi) were subjected to electrophoresis in a 1.5%
agarose gel as described above. The gel was stained with ethidium bromide

and photographed. The PGR products were then transferred from the gel onto a
Genetran nylon filter via methods described by Southern [77] and the

membrane was hybridized with 5'-32p-iabeled 20 nucleotide-long hGH probe
synthesized complementary to the DNA sequence at the 5' end of exon 3(see
Fig. 31 legend for the sequence of the primers and the probe). The probe

detected splicing of intron 2 of the hGH mRNA by the length of the PGR product
that was generated from the RNA template. A 277 bp PGR fragment
represented the final RNA message after splicing of the introns. Hybridizations

in 10 ml of 5X SSPE (IX SSPE = 10 mM sodium phosphate pH 7.0, 0.18 M
NaGI, and 1 mM EDTA), 0.1% SDS, 10 pg/ml of Homo-mix RNA, and 10®
cpm/ml of labeled hGH probe were conducted at 55 °G for 4 hr. Two room

temperature 6X SSG washes for 1/2 hr each were carried out followed by a
single TMAGI wash (see l.2.a.) at 58 °C for 1 hr. The filter was exposed to XAR5 X-ray film at -70 °G for 1 hr with two Dupont Lightning-Plus intensifier screens.

11.3.

RESULTS

The design of the antlsense ollgonucleotldes and the

antlsense ollgomethylphosphonates. The human growth hormone gene

is approximately 1.7 Kilobases long containing four introns [70]. We
constructed the antisense oligomethylphosponates (8 nucleotides long each)
and the oligodeoxyribonucleotides (15 nucleotides long each) in both the
sense and the antisense orientations. Both oligomethylphosphonates

(GH'1,GH'2, GH'3, GH'4, GH01 and GH02) and oligodeoxyribonucleotides

(OGH'15-1, OGH'15-2. OGH'15-3, TLGH1. TLGH2. and AGGH) were designed
to inhibit various steps of the hGH transcript processing and mRNA translation

(see Table 7). GH'1 and OGH'15-1 target the donor site of the splice junction at
the second intron of the hGH message. GH'2 and OGH'15-2 target the acceptor
site of the same splicing junction. GH'3 is an octamer OMR that anneals to the

5' adjacent sequences of the GH'1 annealing site. GH'4 anneals to sequences
in the second intron and serves as nonspecific target controls. GH'TI and
OGH'15-3 block the start site of translation at the first methionine codon while

GH'T2 anneals to the 3' adjacent sequences of the GH'TI annealing site.
TLGH1 (octamer) and TLGH2 (heptamer) are two contiguous oligonucleotides
whose collective sequence is identical to OGH'15-3. AGGH is a polypyrimidine
oligonucleotide that is complementary to a polypurine sequence in the third

intron of the hGH gene. In theory this oligonucleotide can form a triple helix with
the polypurine-polypyrimidine region to block transcription of the hGH gene
[86j.

OGH'15-1 (oligo-dN)
OGH'15-2 (oligo-dN)
OGH'15-3 (oligo-dN)
TLGH1 (oligo-dN)
TLGH2 (oligo-dN)
AGGH (oligo-dN)

GH'1 (OMP)
GH'2(OMR)
GH'3(OMP)
GH'1m1 (OMP)
GH'4(OMP)
GH01 (OMP)
GH02(OMP)
GHTI (OMP)
GHP2(OMP)

Oligonucleotide

complementary to GH'1
complementary to GH'2
block mRNA start site

3' contiguous blocker to GHP1

CTAGGAAG

CATTGGAG
GTAGGTGA

5' octamer of OGH'15-3

3' heptamer of OGH'15-3

TGTAGGGA
TTGGAGG

TTTGGTGGGTGGGGT

polypyrimidine triplex blocker

block translation start site

TGTAGGGATTGGAGG

GAGGTTAGAAAGTGG

acceptor site of splice junction
donor site of splice junction

GGTTGTTGGTAGGAG

GTTTGTAA

nonadjacent control for GH'3

AAAAGCOT

OTACCTAG

mismatch control for GH'1

5' adjacent to GH'1

GAGAAGGA

TTACAAAC

acceptor site of splice junction
donor site of splice juction

Purpose (annealing region)

OTTCCTAG

SEQUENCE

Antisense oligodeoxyrlbonucleotlde and ollgomethylphosphonates

Nucleotlde Sequence of

Table 7

hGH production of stable L cell transformants. Seven pXGH5
transformed cell lines and 12 pTKGH transformed cell lines were stable
transformants. Their hGH production persisted for more than 100 generations
(approximately 30 culture splittings) in tissue culture. Two pXGHS transformed
cell lines became non-producers after approximately 45 generations. The
reason for the loss of the gene expression was unclear since both cell lines
continued to grow at the same rate (approximately 40 hours per doubling).
None of the pTKGH transformed cell lines lost their hGH gene expression.
Repeated freezing of the transformants in 10 % DMSO with liquid N2 and

subsequent thawing did not appear to alter the hGH expression of either
pXGHS or pTKGH transformed cells lines.
hGH production and cell number were followed in cell culture for 7 days

after initial plating (Fig. 25). The cell numbers roughly correlated with the level

of hGH produced in each 24 hr period for both the pXGH5 and pTKGH
transformed LTK" cell lines. Both the hGH production and the cell number

plateaued after six to nine days as the cell cultures were observed to reach
confluency. The approximate doubling time for pTKGH transformed cell lines

was 24 hr and for pXGH5 transformed cell lines was 40 hr. pXGH5 transformed

cell lines however produced 3.5 fold greater level of hGH (6.0 ng/10,000 cells)
than pTKGH transformed cell lines (1.8 ng/10,000 cells) in a 24 hour period.

Cytostatic properties of ollgomethylphosphonates. One pM, 10
pM, and 100 pM GH'2 were used to inhibit the expression of hGH in 3C5 cells, a
stable pTKGH transformant line. Three hundred 3C5 cells were plated in each
well of a 96 well tissue culture plate and allowed to recover overnight. The
medium from each well was then removed and replaced with nutrient medium

Fig. 25. 3C5 Cell hGH production. 305 cells (6000 cells per well) were
plated on day 1 in wells of a 96 well tissue culture plate. Both the cell number
and the medium hGH level were followed for 7 days subsequently. On each

day the medium from each well was removed and replaced with fresh medium
(150 |il). On each day, the cells from duplicate wells were lifted with trypsinversene and counted in a hemacytcmeter. Small aliqucts of the medium
withdrawn from these wells were measured for hGH concentration and adjusted

to give the total hGH present in the well. The hGH level therefore represents
hGH produced by the cells in the well during the 24 hr period prior to the
trypsination.
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containing OMP at the three specified concentrations. The cells remained in the
incubator for 10 days, at which time medium from each well was removed and

assayed for hGH. Half of the wells then received additional OMP containing
medium while the other half received fresh medium without OMP. The cells

were incubated for an additional 3 days to establish cell "recovery" in medium
without OMP. The results are shown in Table 8. Slight suppression of the hGH

level of the 10 day cumulative cell medium was demonstrated only with GH'2 at
extremely high OMP concentration (100 pM). Following the initial OMP
treatment, this suppression was also noted for the next three days in all wells
containing cells that were treated with additional OMP containing medium as
well as cells that were allowed to "recover" in fresh DMEM medium without

OMP. The "recovery" of hGH expression was not observed even 7 days after
the initial OMP treatment. In fact, after three days a slightly lower level of hGH

was found in these "recovering" cells compared to cells that continued to
receive GH'2.

Although the morphology of the 3C5 cells in culture medium with or
without OMP did not appear to be different, an unmistakable suppression of the
cell number was observed in wells treated with 10 and 100 pM OMP. To

elucidate the source of this growth suppression, we compared the growth of the
305 cells in medium containing OMP and in medium containing EDAA, an
HPLC buffer salt, at concentrations equivalent to that would be carried over with

the OMP. Since OMP purification involves a final HPLC step, it is quite
possible that the source of the 305 cell growth inhibition may in fact be EDAA
and not the OMP itself. The results of this growth experiment supported this
hypothesis. At 5 mM EDAA,the same concentration that would have been

(mM)

(mg/ml)

[QMEl

+OMP

hGH level prior to and after recovery

Effect of OMP concentration on

Table 8

(^ig/ml)

30.5

-OMP

carried over with 100 mM OMP in DMEM medium, marked growth inhibition was
seen. In the presence of 5 mM EDAA, cells also were observed to be rounded

with heavily granular cytoplasm and they never assumed the fibroblastic
morphology of other 3C5 cells (results not shown).

Purification of OMP with C18 resins. 0.1 ml of Partisil 40 ODS-3

(C18) resin was used to remove EDAA from the OMP according to the
procedure described in the methods section (ll.b.). 1 ml of GH02(A260nm =
0.643 O. D.) was loaded onto a column containing 0.1 ml of the CIS resin
prewashed with 2 mis of water. The eluent from the loading mixture did not

absorb at 260 nm (A = 0.000) nor did the first 2 mis of water wash (A260 nm =

0.001). Subsequent elution with water-methanol solutions of increasing
strength (25%,50%, and 100%)essentially recovered all the OMP (see Fig. 26).
When this purified OMP was tested for cytotoxicity, it showed no adverse effect
on either 305 or 8G1 cell growth (Fig. 27).

Effect of purified OMP on hGH expression. Freshly plated 305

cells in a 96 well tissue culture plate were treated with antisense OMP's (GH'1,
GH01, and a combination of GH'1 and GH'3) at various concentrations. These
OMP's were previously purified on 018. The overnight hGH concentration of
each well was measured (Fig. 28 A). Significant suppression of hGH
expression in the presence of GH'1 or GH'1/GH'3 combination was not seen

when compared to control GH01 treated hGH expression. The hGH level was
10 to 15 % lower for cells treated with ICQ mM GH'1 and GH'1/GH'3

combination; however, A similar hGH level was observed in the presence of

Fig. 26. Purification of OMR on CIS resin. 018 resin (0.02 g) in
methanol was packed onto a disposable Bio-Rad column and washed with 2 ml
of water. OMR (0.64 O. D. in 1 ml of water) was loaded onto the 018 column

and then rinsed with 2 ml of water. The optical density of the eluent from the
water wash was measured. 1 ml of 25% methanol, 1 ml of 50% methanol and

1 ml of 100% methanol were then used to elute the OMR in stepwise manner.
The optical density of each eluent was measured.

100%MeOH

50% MeOH

25% MeOH

2 ml water

Total O.D.

Optical Density

Fig. 27. Effect of unpurlfled and purified OMP on 3C5 cell growth.
Unpurified and purified OMP [GH01] were added to 3C5 cells plated in a 96
well plate (5000 cells per well) at various concentrations. On the following day,
the cell numbers were measured by first lifting the cells and then counting the
cells in a hemacytometer. The cell number of unpurified OMP treated well at
100 jiM was not reported because the gross abnormal cytomorphology
observed under light microscopy.
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Fig 28. Additive effects of adjacent antisense OMR's. (A) 3C5 cells
were plated at 5000 cells per well density in a 96 well tissue culture plate and
allowed to recover for at least 10 hr. The media from each well was then

removed. GH'1, GH'3, and GH01 were added at various concentrations alone

or in combination to the fresh media in triplicate wells. The cells were incubated

at 37 °C overnight or for 16 hr, upon which time a small aliquot from each well
was removed and assayed for hGH concentration. The value reported in the
figure represents the average total hGH in the triplicate wells. Cells were
monitored for cytomorphology but cell number was not counted. (B) Same
experimental procedures were applied as in (A). GHT1, GHT2, and GH01
were applied alone or in combination at the concentration indicated.

MS

GH'3 + GH'l

Antisense OMP concentrations (uM)

control GH01. Three day cumulative hGH level In the medium was also
measured for 305 cells treated with various concentrations of GH'T1, GHT2 or

GHT1/GHT2 combination (Fig. 28 B). Again no significant difference in the
hGH level can be demonstrated for wells treated with either GHT1 or GHT2.

Treating the cells with a combination of GH'T1 and GHT2, however, did have
an additive inhibitory effect at 100 ^iM concentration.

Transient antisense Inhibition assay with
oligodeoxyribonucieotides. Antisense pentadecamer oligonucleotides are
highly charged molecules that may have difficulty crossing the hydrophobic cell

membrane. To ensure that these antisense oligonucleotides reach the
cytoplasm, the site of their actions, we decided to include various molar ratios of
the antisense oligonucleotides to hGH plasmid DMA in the calcium phosphateDNA precipitation procedure. Since calcium phosphate-DNA precipitate are
phagocytized, an expected number of antisense oligonucleotide would be

taken up by the cells for each copy of hGH gene containing plasmid. In these

experiments, 10"^ LTK" cells were plated in each well of a 24 well tissue culture
plate and allowed to recover overnight in DMEM without HAT. Calcium
phosphate-DNA precipitates were prepared the following day and were used to
tranfect the LTK" cells. On the third or the fourth day following the initial plating,

the medium from these wells were withdrawn and assayed for hGH.

Initial experiments using this type of transient assay demonstrated an
apparent inhibitory effect of the antisense oligonucleotides. The inhibitory
effects appeared to be dose dependent and specific as the control tetradecamer

oligonucleotide (0NA3), complementary to the p-globin gene at equal ratio, did
not suppress the hGH level (Fig. 29 A). The inhibition could also be

Fig. 29. Time and dose dependence of hGH gene inhibition by

antisense oligodeoxynucieotides in transient assays. (A) Transient
antlsense assays were performed as described in Methods section. Plasmid
pTKGH (1 pg or approximately 0.25 pmol) were used for transfection in the
calcium phosphate-DNA precipitation procedure. OGH'15-1, OGH'15-2,
OGH'15-3 and 0NA3 were included in the precipitation mixture at 125, 250,
500,1000, 2000, or 4000 fold above the concentration of pTKGH. Overnight
hGH levels were reported above as % of no antisense oligo-dN control. Cell
numbers were not reported because of difficulties in performing hemocytometer

counts in the presence of cell debris. (B) OGH'15-1, OGH'15-2, OGH'15-3 and
0NA3 were used in the co-transfection at 4000 fold above the concentration of

pTKGH. The cumulative hGH level in the tube was followed for 7 days by
withdrawing 25 pi aliquots from the medium at appropriate times. Cells were
plated at 25,000 cells per well in a 12 well plate and maintained with 1 ml of
DME media.
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demonstrated for up to seven days after transfection (Fig. 29 B). However
although some Inhibition was demonstrated for each assay, the inhibitory
effects was not always reproducible quantitatively, as shown in Table 9. In
three separate experiments with identical oligonucleotides at 4000:1

oligonuceotide to hGH gene ratio, the % inhibition varied from 71% to 96% with
OGHT5-2 antisense oligonucleotide. The greatest inhibition was consistently
observed for OGH'15-3, a pentadecamer complementary to the start site of hGH
gene translation.

Effects of calcium phosphate procedure on 3C5 cells. The
results of the transient assays did not rule out the possible cytostatic effect of

calcium phosphate transfection procedure on LTK" cells. We designed a set of
parallel experiments comparing 3C5 cell hGH expression and cell growth
using either oligonucleotides coprecipitated with calcium phosphate-DNA or

oligonucleotides added after the calcium phosphate-DNA precipitate. In the
latter case, antisense oligonucleotides were added to give a final concentration

of 0.3|i.M or equivalent to 4000:1 molar ratio of oligonucleotide to hGH gene.
The hGH production of those cells treated with oligonucleotide coprecipitated
with calcium phosphate-DNA and those cells treated with oligonucleotides
added subsequently to calcium phosphate-DNA precipitation were compared
(Table 10). We also examined the hGH level of 3C5 cells treated with the
antisense oligonucleotide but without any calcium phosphate-DNA precipitates.
The results revealed a the cytotoxic effect of calcium phosphate-DNA

precipitation on the LTK" cells. When the calcium phosphate precipitation was
not performed, the hGH concentrations measured in the medium were

approximately same (range from 24.0 to 25.5 ng/ml) for cells either treated and

OGH'15-1#

OGH'15-2#

OGH'15-3#

100%
101%

#- All antisense oligonucleotides were included at 4000:1 over the concentration of pTKGH.

Contois in each experiment.

100%

100%

no ollgo

100%

0NA3#

- hGH level from each of the transient expression assays are expressed as% of no oligonucleotide

Exp.

Results of three antlsense transient assays

Table 9

not precipitated#
(ng/ml)

amtatK

no calcium phosphate@
(ng/ml)

@ - Antisense oligonucleotide were added without caicium phosphate precipitation.

to the weiis subsequentiy.

# - Antisense oligonucleotides were not inciuded in the calcium phosphate precipitation but added

* - Antisense oligonucleotides were included in the calcium phosphate precipitation procedure.

copreclpltatlon v/l*
(ng/ml)

Table 10

untreated with 0.3

antisense oiigonucleotide (column c). Approximate three

fold Inhibition was observe when calcium phosphate-DNA procedure was
performed but ollgonucleotldes were not copreclpltated with the DNA (compare

columns b and c). Furthermore, the varying degree of Inhibition by the different
antisense oiigonucleotide was not found when the ollgonucleotldes were
added subsequently to calcium phosphate-DNA precipitates (compare columns
a and b).

Direct treatment of 3C5 cells with antisense oiigonucleotide.

Antisense ollgonucleotldes were also tested for their ability to directly Inhibit the
hGH gene expression In stable 3C5 transformants. The antisense
ollgonucleotldes were Included In the medium of each well at the time of the cell

plating at various concentrations Involving neither the calcium phosphate nor
the llpofectlon procedures [87].

All ollgonucleotldes OGH'15-1, OGH'15-2,

OGH'15-3. AGGH. TLGH1, TLGH2, AGGH,and TLGH1/TLGH2 combination

exerted dose dependent Inhibitory effect on 3C5 cell hGH production when
added directly to the tissue culture medium (Fig. 30). In contrast, 0NA3 had a
very minor Influence on the hGH production. AGGH, designed to Inhibit

transcription, had the maximal inhibitory effect on hGH production exhibiting
81% Inhibition when compared to the control. Whereas OGH'15-1 and

OGH'15-2 both Inhibited the hGH level by approximately 50%, OGH'15-3, which
had the greatest Inhibitory effect In transient assays (see Fig 30 A), reduced the
overnight hGH level by only 29%.

We also tested the Independent and combined Inhibitory effects of

TLGH1 (octamer whose sequence Is Identical to the first eight nucleotldes of
OGH'15-3) and TLGH2(heptamer whose sequence Is Identical to the last seven

Fig. 30. Direct inhibition of hGH gene by antisense

oiigonucieotides. 3C5 cells were plated in 96 well plates (5000 cells per
well) and allowed to recover overnight. The medium (approximately 150 pi)
from each well was removed the following day and replaced with medium
containing antisense oiigonucieotides at 1.25, 2.5, 5, or 10 pM concentration.
The hGH level was measured the following day after 24 hr of incubation at 37
°C. The data were expressed as % of hGH produced by 3C5 cells in control
wells which were given medium without oligonucleotide. (A) Effect of OGH'151, OGH'15-2, OGH'15-3, AGGH and 0NA3 on hGH levels.(B) Effect of TLGH1,
TLGH2, OGH'15-3, and 0NA3 on hGH levels. TLGH1 and TLGH2 were also

used in combination. Data points represent the average result from triplicate
wells.
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nucleotides of OGH'15-3)(Fig. 30 B). At 10 |j.M Inhibitor oligonucleotide
concentration, TLGH1 and TLGH2 had minimal suppressive effects on the hGH

level, 4 and 12 %, respectively. When used as a combination at 10 pM each,
however, the overnight hGH level were reduced by 35% as compared to the
control. This value was similar to the 29% inhibition of hGH level in 3C5 cells
treated with 10 pM OGH'15-3.

The experiment described in Fig. 30 represented a typical direct

inhibition study with the oligonucleotides obtained from the City of Hope DNA
synthesis facility. However when the source was switched to a Texas based

DNA synthesis facility, these results could not be reproduced, even at 25 mM
oligonucleotide concentration (results not shown). No significant difference

could be found between the level of the hGH production in the presence of
inhibitory antisense oligonucleotides and in the presence control
oligonucleotides.

hGH mRNA and precursor levels in Inhibited 305 celis. The

polymerase chain reaction was used to quantitate the level of the hGH mRNA

and its RNA precursor level for 305 cells directly treated with 10 pM
oligonucleotides. A first round of RNA dependent DNA synthesis was
performed with MLV reverse transcriptase on total genomic RNA isolated from

the 305 cells. Fifteen subsequent rounds of FOR with Tag polymerase were

then performed. PGH1 and PGH2(both octadecamers) directs the synthesis of
a 405 bp fragment across exons 2 and 3 including intron 2 from the
unprocessed hGH RNA transcript. In contrast, these primers directs the

synthesis of a 227 bp fragment from the hGH mRNA itself since the 178 bp
intron 2 is removed during post-transcriptional processing. The POR products

were separated by agarose gel electrophoresis, Southern transferred onto a
nylon membrane, hybridized with an internal oligonucleotide probe

(nonadecamer), and autoradiographed (Fig. 31). The mRNA to precursor ratio
was quantitated by scanning the nylon membrane with the Ambis radioisotope
scanning system II (Fig 31). OGH'15-1, OGH'15-2, and OGH'15-3 (Fig. 31,
lanes b, c, and d) reduced the mRNA to precursor ratio from the control level of
4.2(lane g)to 1.2-2.0. Both 0NA3 and AGGH did not affect the mRNA to
precursor ratio (lanes e and f), as expected.

Fig. 31. Precursor and messenger RNA levels In 3C5 cells treated
with antlsense ollgonucleotldes. 3C5 cells (5000 cells per well) were
plated in a 96 well dish and treated with medium containing 10 mM antisense
oligonucleotide (b- OGH'15-1, c- OGH'15-2, d- OGH'15-3, e- AGGH,f- 0NA3, gno oligonucleotide control). RNA's from these cells were isolated via the
RNAsol method as described in the Methods section. Immediately after
isolation, the RNA pellets were resuspended in 100 pi of DEP treated water.

Ten ml of each sample was used for reverse transcription using MLV reverse
transcriptase (5 units) for 10 min at 37 °C in the presence of GHPCR5'and
GHPCR3' primers. PGR was subsequently carried out with 2.5 units of Taq
polymerase for 20 rounds: annealing at 55 °C for 2 min, elongation at 72 °C for
3 min. and denaturation at 94 °C for 1 min. 15 pi of each sample was subjected
to electrophoresis at 120 V for 3 hr in 1.5 % agarose gel. Southern transfer of

the gel onto Genetran nylon membrane was then performed in 20X 880 buffer
overnight. The filter was then hybridized to hGH probe at 57 °C for 4 hr and
washed as described in the Methods section. mRNA to precursor ratio was

measured by scanning on Ambis Radioisotope Scanning System II. Lane a
contained PGR products of hGH plasmid control using 1 ng of pXGH5 carried
through 20 rounds of PGR as described above. The product is a single 405
base-pair fragment.
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DISCUSSION

The idea of antisense inhibition derived from studies of prokaryotic gene

regulation [107, 108]. The term "antisense" has been coined to describe the
function of certain RNA species which can directly control gene expression.
These antisense RNAs are highly specific in their repression of gene

expression presumably by binding to complementary sequence specific regions
of the target gene. Antisense RNA has been implicated in several gene

regulatory phenomena in bacteria, such as TnIO transposition, phage
reproduction, and autoregulation of cAMP-receptor protein synthesis [49, 109,
110]. These findings led logically to the exogenous application of synthetic
RNA and DNA as artificial gene regulators [51, 52]. Short synthetic

oligonucleotides and oligomethylphosphonates are regularly used as antisense
inhibitors for two reasons. First, short synthetic oligonucleotide and especially
the OMR's have been demonstrated to cross the hydrophobic cell membrane

and enter the cytoplasm [111, 112]. And second, short synthetic
oligonucleotides are easily made with automated DNA synthesizers.
In this study we examined the phenomenon of antisense inhibition by

synthetic oligonucleotides in a defined system. We co-transfected LTK- cells
with the thymidine kinase gene and a plasmid containing the hGH gene using
the calcium phosphate-DNA precipitation method. In the presence of

aminopterin, hypoxanthine, and thymidine, only cells expressing the thymidine

kinase gene could metabolize the thymidine and remain alive after 20 days of
selection. In each case, cells that survived also expressed the hGH gene

indicating that the phagocytic uptake of the calcium phosphate-DNA precipitate
was efficient, and the uptake was also non-selective in term of DNA size. In all

probability, many molecules of DNA were taken up by each LTK- cell; however,
the subsequent expression of the thymidine kinase gene may be rather low.
Nevertheless, we were able to obtain stable transformants with both pTKGH

and pXGH5 plasmids. 12 pTKGH and 7 pXGH5 containing clones were
isolated. These clones stably expressed hGH for at least 45 generations, at
which time, two pXGHS containing clonal lines lost their hGH gene expression.
Other clonal lines remained stable.

Three aspects of sequence specific antisense inhibition were examined

in the present study. The antisense oligonucleotides were designed to inhibit 1)
the post-transcriptional splicing step at either the donor or the acceptor sites, 2)
the translational step at the first methionine codon of translation, and 3)the
transcriptional step at a stretch of polypurine-polypyrimidine sequence which
could permit the formation of a DNA triple helix. In addition, we also compared
the efficacy of two shorter contiguous oligonucleotide blockers relative to a
single longer oligonucleotide to the same antisense site.

A major problem in measuring the effects of these antisense

oligonucleotides on cells growing in tissue culture is the possible cytotoxicity of
the perturbing agent. Initial studies with unpurified antisense OMP (GH'1)
showed a moderate inhibition (25%) of hGH production in 3C5 transformants at
100 pM concentration. However, some growth inhibition was also observed

(Table 8 and Fig. 27). The growth inhibition alone could account for the change
in hGH production observed with unpurified GH'1 at high concentrations. This
conclusion was further substantiated by the fact that cells recovering in media
containing no OMP continued to display the same inhibitory pattern as the cells

growing in OMP containing medium (Table 8). A major source of the OMP
cytotoxicity turned out to be the HPLC buffer salt, EDAA, which was carried into

the medium with the OMP, EDM was easily removed with C18 hydrophobia
chromatography and the OMP was recovered by methanoi (Fig. 26). Purified
OMP used to treat 305 cells showed no adverse effect on either 305 or 8G1 cell

growth, even at high concentrations (Fig. 27).
Purified OMP continued to exert an inhibitory effect on hGH production by
305 cells at 100 pM concentration; but, the inhibition was slight(approximately

10% each with GH'1, GHPI and GHT2)(Fig. 28 A and B). A similar level of
inhibition was also observed with 100 pM GH01, a control OMP complementary

to intron 1. When added in combination, OMP's designed to anneal to adjacent
sequences on hGH mRNA at either the donor splice junction (GH'1 and GH'3)

or the translation start site (GHTI and GHT2)showed additive inhibitory effect
of approximately 20 to 25%. This observation however could not be attributed
to the sequence specific inhibition by antisense OMP's alone. It is quite

possible that cytostatic or cytotoxic effects persisted with the purified OMP's. At
100 pM concentration, for example, the GHT'1 / GHT'2 combination had a

profound cytotoxic effect on the 305 cells (Fig. 28 8). The same cytopathology
was not seen with the GH'1 / GH'3 combination at the same concentration.

Oytotoxic effects of antisense oligonucleotides appeared to be equally
important in the transient assays. With the oligonucleotide calcium phosphateDNA co-precipitation method, dose dependent inhibitory effects were
demonstrated for OGH'15-1, OGH'15-2, and OGH'15-3 at 4000:1

oligonucleotide to gene ratio (Fig. 29 A). Inhibitory effects were not observed
with control oligonucleotide 0NA3, which is complementary to the p-globin

gene. Calcium phosphate precipitation however was toxic to 305 cells

(compare Table 10 Column b with column c). In the toxicity experiment (Table.
10), when oligonucleotide was not co-precipitated with calcium phosphate, the

hGH inhibition by the antisense oligonucleotides was abolished (compare
Table. 10 column a with column b). This result was expected since only 0.3 pM
oligonucleotide would have been present in the medium, a level far below an
effective concentration required for direct inhibition as reported previously [61].
Although the inhibition of the hGH gene expression by the antisense
oligonucleotides co-precipitated with calcium phosphate-DNA could exert a

sequence specific effect, cytotoxicity from the calcium phosphate-DNA mixture
should still be considered as an important confounding factor in the

interpretation of these antisense transient assay results. Furthermore, the
quantitative inhibitory effects of the antisense oligonucleotide could not be

reproduced with consistency therefore making the transient assay an unreliable
method of examining antisense effects in our system.
When added directly into the tissue culture medium, nearly all antisense

oligonucleotides exhibited variable levels of dose dependent inhibition of the

overnight hGH gene expression (Fig. 30). Control oligonucleotide 0NA3 did
not produce any inhibitory effect on the 305 cells. In this type of assay system,

AGGH (pentadecamer) surprisingly had the greatest inhibitory effect (81 %).
AGGH is a polypyrimidine oligonucleotide designed to form a triple helix with a

stretch of polypurine-polypyrimidine sequence at intron 2; therefore, it is only
expected to affect the hGH gene expression at the transcription level. The
conditions reported by Moser and Dervan for DMA triple helix formation involves

moderate pH (7.4) and NaCI concentration (100 mM), both of which can occur
in vivo [86]. However, the triple helix can only form under extreme dehydrating
conditions (i.e., 40% polyethyleneglycol is used to remove water from the major
groove of the DMA double helical structure, thereby allowing a third pyrimidine
nucleotide to form hydrogen bonds with the existing base pair)[113]. In vivo the

Hoogsteen hydrogen bonding, therefore, was not expected to form effeciently.

Since AGGH is expected to block at the transcription level, some hGH message
should have already existed in the cell at the time of the block and hGH

production is therefore not expected to be affected immediately. For these
reasons, the 81% inhibition by AGGH may have been the result of other
mechanisms than triple helix formation with the oligonucleotide. Furthermore,

when PGR was used to measure the level of hGH mRNA precursor, a significant
decrease was not observed in cells treated with AGGH at 10 mM (Fig. 31 lane
e).

With the direct inhibition assays, we also tested the independent and
combined inhibitory effects of TLGH1 (octamer whose sequence is identical to

the first eight nucleotides of OGH'15-3) and TLGH2 (heptamer whose sequence
is identical to the last seven nucleotides of OGH'15-3)(Fig. 30 B). When used
in combination, TLGH1 and TLGH2 produced a greater inhibitory effect (35%)
than the sum of the independent effect by each oligonucleotide (4 and 12%,

respectively). This observation suggests that the two contiguous
oligonucleotides may act cooperatively to inhibit translation at the start site.

Recently, Maher and Dolnick have suggested that two contiguous

oligonucleotides may stabilize one another's interaction with the target
sequence such that they act as one continuous longer oligonucleotide [114]. In

fact, this may have been a likely explanation in our case as the TLGH1/TLGH2
combination inhibited the hGH level to the same extent as OGH'15-3 alone

(29%).

The mechanism of antisense oligonucleotides was investigated by
quantifying the levels of the hGH mRNA and the message precursor in 305
cells when treated with various antisense oligonucleotides. A pair of

polymerase chain reaction primers were used to direct the amplification of a
405 bp fragment from the hGH mRNA precursor including intron 2 (Fig. 31).
These primers also directed the synthesis of a 227 bp fragment from the hGH
message itself since the 178 bp intron 2 was removed during post-transcription
processing. Both OGH'15-1 and OGH'15-2 inhibited the overnight hGH level

produced by 3C5 cells by some 50 % when they are added at 10 pM

concentration. Since, OGH'15-1 and OGH'15-2 both block the splicing process,
the expected mRNA to RNA precursor ratio would be lowered as RNA precursor
accumulates. This was observed in 305 cells treated with either of the two

antisense oligonucleotides (Fig. 31, lanes b and c) as mRNA to precursor ratio
were decreased from 4.2 to 2.0 for OGH'15-1 and 1.8 for OGH'15-2.

Interestingly, the greatest effect on mRNA to precursor ratio was observed with

OGH'15-3 (1.2) even though this oligonucleotide was designed to block
translation (Fig. 31 lane d).

The results of our present work does not argue conclusively for or against
a specific mechanism by which antisense oligonucleotides act on eukaryotic
gene expression. In fact, the interpretation of our results has been made even

more so difficult by the cytotoxic effects of both oligodeoxynucleotides and
oligomethylphosphonates on the L cell transformants. Two observations,

however, are noteworthy in the present study which may lend support to
sequence nonspecific mechanism of antisense inhibition. Firstly, OMR's

appeared to be much less effective in inhibiting the hGH gene expression than

oligodeoxyribonucleotides even though OMR's should cross the cytoplasmic
membrane with greater efficiency. A possible explanation for this observation is

that RNAse H participates prominently in the antisense action. Hence, since
OMR's are not substrates for RNAse H [115], target specific destruction of RNA

would occur only when ollgodeoxynucleotides were used. Secondly, the

surprising inhibitory effect exerted by AGGH and the reduction of mRNA to
precursor ratio by OGH'15-3 both argue against sequence specific blocking of

RNA by complementary oligonucleotides. As suggested above, neither
oligonucleotide altered the mRNA to RNA precursor level in the predicted
direction. It should therefore be argued that a mechanism other than sequence
specific blocking exists which inhibits hGH gene expression yet it is rather nonselective for the precise target of the antisense oligonucleotide.
This study conclusively demonstrated the confounding effects of OMR

and oligodeoxyribonucleotide cytotoxicity at high concentrations in the overall
interpretation of the inhibition data. In future studies, cell growth should always
be monitored for cytotoxic effects and the results should be adjusted in terms of
cell number. The scope of the present study unfortunately does not permit a
conclusive demonstration of the sequence non-specific mechanism of
antisense oligonucleotide action. Such a demonstration would require

changing the target sequence of the antisense binding site with site directed
metagenesis and observing the inhibitory effects of the antisense

oligonucleotide on both the normal and the mutated target.
In the present work, we have devised a system to study the mechanism of
antisense oligonucleotide inhibition of a target gene. This system offers the
unique advantage that the gene product could be monitored without disrupting
cells in culture. hGH was easily measurable with commercially available
radioimmunoassay methods. Furthermore the actual RNA precursor and
message levels could be distinguished and quantitated by the polymerase

chain reaction directed with a pair of primers.

NOTE

Derivation of kinetic equation governing polymerase chain reaction priming
efficiency:

kon .
P + DMA 4<jNTP4-——

kpoi
P...DMA

► P*DNA

► Polymerization

koff

d/dt [P...DNA] = kon [P] [DMA] [dNTP] - koff [P...DNA] - kpoi [P...DNA]
steady state condition is valid because kpoi > koff for most catalytic systems;
therefore, d/dt [P...DNA] = 0

solving for [P...DNA], [P...DNA] = kon / koff + kpoi [P] [DMA] [dNTP]
Since [P*DNA] = kcat [P...DMA], substituting the above equation for [P...DMA]

[P*DNA] = kon kpoi / koff + kpoi [dNTP][P][DNA]
(P -- Primer; dNTP -- deoxyribonucleotide phosphate; P...DNA - loose
associated primer -template complex; P*DNA -stably formed primer template complex)
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